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Abstract 
Stresses from the external environment can disrupt cellular processes and result in damaging 
effects, such as the misfolding of proteins, which have been linked to several diseases. 
Regulator of G protein signalling 2 (RGS2) is upregulated by several forms of stress and can 
inhibit protein synthesis, an established response to stress typically achieved via the 
phosphorylation of the initiation factor, eIF2, to conserve energy and resources. Under 
reduced translation, some factors are selectively expressed via alternative translation 
mechanisms and these factors consequently may promote apoptosis. The molecular 
mechanisms mediating such opposing responses to stress are not well understood. Here, we 
suggested that RGS2 may be an important regulatory component in the cellular stress 
response and we hypothesized that RGS2 contributes to the response of cells to stress 
through its translational control abilities. Previously, we have shown that RGS2 can interact 
with the translation initiation factor, eIF2B, and inhibit de novo protein synthesis. Here, we 
demonstrated that the expression of RGS2 decreased total protein levels and significantly 
increased levels of factors linked to stress-induced apoptosis such as ATF4 and CHOP. 
Interestingly, expression of the eIF2Bε-interacting domain of RGS2 (RGS2eb) alone resulted 
in a 20-fold increase in caspase 3 activation which was not seen with full-length RGS2. 
Furthermore, we showed that these effects are translationally regulated and independent of 
eIF2 phosphorylation. Thus, we present a novel mechanism in the regulation of stress 
response by RGS2. These results also suggest that RGS2 may be pro-apoptotic and may 
potentially be an important target in stress-related pathologies. 
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Chapter 1  
1 Introduction 
1.1 Cellular responses to stress: Cell survival and cell 
death 
One of the major features of cells is the maintenance of intracellular levels of important 
ions, metabolites, and biomolecules such as lipids, polysaccharides, nucleic acids, and 
proteins, to sustain proper cellular function and homeostasis. At the same time, cells are 
exposed to a constantly changing environment which may include stressful stimuli that 
can damage or cause imbalances in such macromolecules. These include stresses such as 
nutrient deprivation, temperature fluctuations, hypoxia, oxidative damage, exposure to 
toxins or ultraviolet radiation, mechanical damage, and viral or bacterial infections. 
Appropriate responses to stress therefore must be in place to adapt to changes in the 
physiological environment to prevent or ameliorate aberrant functions. The cellular stress 
response (CSR) is a highly conserved mechanism coordinating gene expression and 
protein translation to serve as an adaptive response to alleviate the stressful state
1,2
. 
Features of the CSR include increases in the expression of proteins involved in 
reparative, restorative, or pro-apoptotic effects, where such changes are mediated through 
several processes and pathways including heat shock response, mitogen-activated protein 
kinase signalling, proteasomal systems, and the unfolded protein response
1,2
. While initial 
responses toward cell survival via repair and recovery pathways are expected, it is 
understood that cell death may be preferable to remove dysfunctional cells should 
recovery be unsuccessful. Whether cells pursue a protective or destructive stress response 
may be dependent on the nature and severity of the stress as well as the cell type. Studies 
have shown selective responses in vitro and in vivo that are dependent on the type of 
stress
3,4
, however the molecular mechanisms regulating the switch between survival or 
death of a cell is not well understood. 
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1.2 Cellular stress pathways: Endoplasmic reticulum (ER) 
stress 
The endoplasmic reticulum is a major organelle in the cell that regulates several 
important cellular activities. These activities include protein synthesis and post-
translational quality control processes such as protein folding, modification, and 
trafficking; calcium homeostasis; lipid and steroid metabolism; and drug detoxification
5–
8
. The ER also modulates the degradation of misfolded proteins via a process known as 
the ER-associated degradation (ERAD) pathway which involves recognition and 
targeting of nascent misfolded proteins in the ER for retro-translocation to the cytosol for 
disposal by the ubiquitin-proteasomal degradation pathway
9,10
. The recognition step 
includes the detection of exposed hydrophobic regions (e.g., by BiP chaperones), broken 
cysteine bonds (e.g., by protein disulfide isomerases), or improper glycan attachments 
(e.g., by lectins such as calnexin, calreticulin, or other glycosyltransferases) of misfolded 
proteins
9
. After cycles of refolding and re-glycosylation, terminally misfolded proteins 
are recognized by HRD E3 ubiquitin ligase complexes located within the ER membrane, 
which serve to translocate peptides to the cytosol where they are ubiquitinated and 
degraded by 26S proteasomes
9
. Stressors such as heat shock, oxidative stress, ischemia, 
and pharmacological agents such as tunicamycin (an N-glycosylation inhibitor) and 
thapsigargin (a sarco-endoplasmic reticulum calcium-ATPase inhibitor) can lead to 
improper protein folding or unfolding and disrupt the integrity of the ER, thereby 
inducing ER stress and associated pathphysiological states
11–16
. 
1.2.1 Proteotoxic stress and associated diseases 
Proteins are one of the main biomolecules involved in virtually every living process 
whose functions are determined by their structural integrity and functional properties. 
Dysregulation in protein synthesis, quality control processes, or damages in protein 
structure by external perturbations can cause proteins to misfold or unfold and become 
dysfunctional. Aggregation of such misfolded proteins and impairments in proteasomal 
pathways that function to ubiquitinate, degrade, and remove such proteins can lead to ER 
stress and a number of disorders and pathologies
17,18
. A growing body of work shows that 
ER and proteotoxic stress are linked to various diseases such as diabetes, inflammation, 
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metabolic and cardiovascular diseases, cancer, and neurodegenerative disorders
11
. 
Impairments in lipid metabolism due to the disruption of lipid metabolizing enzymes or 
secretory pathways involved in cholesterol efflux can lead to lipotoxicity
19
 and impaired 
hepatic function
20
. Nonetheless, it is important to note that levels of protein synthesis are 
under constant flux depending on the current physiological needs of the cell; hence, 
regulation of the pathways within the ER is essential for its integrity and functionality. 
Understanding the molecular pathways regulating protein translation and activation of 
specific pathways in response to ER stress may reveal important therapeutic targets to 
combat ER stress-related diseases. 
1.2.2 The unfolded protein response (UPR) 
Cells respond to stress through either of two major pathways: the upregulation of 
molecular mechanisms involved in cell recovery and survival
14,15
, and intrinsic signalling 
cascades leading to apoptosis (programmed cell death)
21–24
. During times of ER stress, a 
set of signaling pathways known as the unfolded protein response (UPR) is activated, and 
this response involves the change in expression and/or activity of several molecular 
components that functions to alleviate stress in the ER and/or induce apoptosis. The UPR 
functions in three major ways to decrease the accumulation of misfolded proteins via: i) 
increased protein degradation through ubiquitin-proteasomal ERAD
9,25
 or lysosomal
25
 
pathways to reduce protein overload, ii) increased protein folding capacity via 
upregulation of molecular chaperones to assist in protein refolding
1,26
, and iii) transient 
inhibition of protein translation to reduce protein load and allow for recovery and 
refolding pathways to “catch up”22,27–29. Notably, recent studies have also shown stress-
activated changes of the ER itself to alleviate stress. This includes greater lipid 
biosynthesis to increase the size of the ER, which studies show that this is mediated by 
both UPR-dependent and independent signalling
30
. Increase in ER size allows for the 
accommodation of higher protein load within the lumen of the ER and heightened stress-
adaptive functions such as chaperone-mediated folding during ER stress
30
. 
The maintenance of proper protein folding involves a lumenal ER chaperone known as 
binding immunoglobulin protein or the 78 kilodalton glucose-regulated protein 
(BiP/GRP78), which functions to ensure proper protein folding of nascent peptides. 
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Under quiescent conditions, the majority of the available molecules of this chaperone are 
bound to and repress the activity of three ER transmembrane sensors: PKR-like ER 
kinase (PERK), inositol requiring enzyme 1 (IRE1), and activating transcription factor 6 
(ATF6)
11,25,26
. Upon an increase in unfolded or misfolded proteins during ER stress, BiP 
translocates from these sensors and binds to hydrophobic regions of the misfolded 
proteins to facilitate folding via ATP-dependent processes
11
. Dissociation of BiP leads to 
the activation of the sensor proteins, each shown to activate particular sets of downstream 
effectors, resulting in different cellular outcomes to remediate ER stress
13,22,24,27,31
 (Fig. 
1.1 A, B). Furthermore, structural studies on the lumenal domain of IRE1 show that it is 
involved in the recognition and binding of misfolded proteins as part of its ER stress-
sensing functions
9,32
. 
Derepression of PERK due to increased BiP association with misfolded proteins in the 
ER leads to its activation involving homodimerization and autophosphorylation of its 
cytoplasmic serine/threonine kinase domain
33
. Activated PERK subsequently 
phosphorylates the alpha subunit of the eukaryotic initiation factor 2 (eIF2α) at serine 51, 
which interferes with the formation of the 43S translation initiation complex
11,34
. This 
results in transient global inhibition of protein synthesis at the initiation stage of 
translation to prevent further protein load in the ER
13,16,35,36
. Interestingly, the decrease in 
translation leads to preferential expression of particular factors involved in stress 
response, such as activating transcription factor 4 (ATF4), whose protein levels are 
present at very low amounts during non-stressed states
37
 and substantially increase during 
ER stress
33,38–40
. In addition to decreasing protein synthesis to reduce ER load, the PERK-
mediated phospho-eIF2α pathway, along with the two other branches of the UPR, 
induces gene expression of several targets to mount a response against stress
41
. 
Similar to PERK, activation of IRE1 upon the release of BiP involves homodimerization 
and autophosphorylation through its cytoplasmic kinase domain
25
. Unlike PERK, the 
cytoplasmic C-terminal portion of IRE1 also contains an endoribonuclease domain that is 
shown to alternatively splice the mRNA of X-box binding protein 1 (XBP1), resulting in 
a transcription factor (XBP1s) that increases the transcription of several stress response 
genes
11,25,42
. The resulting IRE1-XBP1s pathway leads to reduced protein load and 
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removal of misfolded proteins via increased transcription of genes involved in ERAD
11
. 
Additionally, XPB1s has been linked to greater protein folding capacity through 
increased expression of ER chaperones such as BiP, and is also involved in the 
expression of proteins involved in lipid synthesis and ER biogenesis
43–46
. A process 
known as the regulated IRE1-dependent decay (RIDD) of mRNA is also involved in 
response to cell stress, where IRE1 degrades mRNA localized to the ER via its RNase 
activity to decrease the amount of translation and therefore reduce ER protein load
43
. 
Several substrates targeted by the RNase activity of IRE1 have also been identified to 
result in a global decrease in protein synthesis, such as the cleavage of ribosomal 28S 
rRNA
43,47
, to alleviate ER stress. 
Unlike the two previously described ER transmembrane sensor proteins, activated ATF6 
is itself a transcription factor that goes on to activate many UPR target genes
42,48,49
. The 
cytoplasmic portion of ATF6 consists of a DNA-binding domain containing a basic-
leucine zipper motif (bZIP) that is involved in regulation of gene expression
11
. Upon ER 
stress, dissociation of BiP reveals the lumenal domain of ATF6 that contains a Golgi-
localization signal, thereby allowing it to translocate to the Golgi apparatus. From there, 
ATF6 is sequentially cleaved by site 1 (S1P) and site 2 proteases (S2P), resulting release 
of a 50 kilodalton cytoplasmic fragment of ATF6 that translocates to the nucleus and 
activates the transcription of ER chaperone genes such as BiP, GRP94, and 
calreticulin
11,50
. 
The highly involved processes within the UPR are therefore important to coordinate the 
appropriate response to ER stress. In fact, disruption of the activities of the UPR, such as 
in the PERK, IRE1, or ATF6 pathways, can prevent an appropriate ER stress response, 
thereby further exacerbating the pathophysiological state
12
. This has been seen in 
neurologic diseases such as Alzheimer’s and Huntington’s disease5,11,51, cardiovascular 
diseases
13,21–24,52
, metabolic and liver disease
11,53
, pancreatic inflammation and 
diabetes
8,54–56
, and more recently in cancer
7,57
. ER stress has been associated with 
hypertrophic myocardium in humans and mice, and targeted increase or decrease in the 
activity of the UPR has been shown to lead to different physiological outcomes of the 
heart
27
. 
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Figure 1.1. Molecular pathways involved in ER stress and the unfolded protein 
response (UPR). (A) Under non-stressed conditions, the majority of BiP proteins are 
bound to ER transmembrane sensor proteins PERK, IRE1, and ATF6, leading to the 
repression of transmembrane sensor functions. (B) BiP is depleted upon the accumulation 
of misfolded proteins leading to differential activation of signalling cascades to reduce 
protein overload or the induction of apoptotic pathways (caspase activation). 
A 
B 
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1.2.3 ER stress induced apoptosis and diseases 
Paradoxically, some ER stress-activated factors involved in the UPR can promote both 
cell survival and apoptosis
58
. Little is known about the regulatory mechanisms mediating 
such opposing endpoints, although it is expected that upon irreversible damage, pathways 
leading to apoptosis are initiated to alleviate further dysfunction. ER stress-activated 
apoptotic pathways have been shown to be active in neurodegenerative diseases, 
atherosclerotic lesions, metabolic disorders, and heart failure
21,27,57
. Several studies have 
shown the increase in gene and protein expression of ER stress-induced apoptotic factors 
linked to such diseases
27
. 
1.2.3.1 ATF4-CHOP mediated apoptosis and diseases 
As mentioned earlier, phosphorylation of eIF2 leads to the general inhibition of protein 
synthesis at the initiation step of mRNA translation and upregulates specific stress 
response effectors such as ATF4 through alternative translational mechanisms
59–64
. ATF4 
is a stress-activated nuclear transcription factor belonging to the activating transcription 
factor/cAMP response element binding protein (ATF/CREB) family of proteins. 
Members of this protein family are involved in regulating the transcription of pro-
survival and pro-apoptotic targets that contain CCAAT-enhancer binding protein 
(C/EBP)-ATF response elements in their genes
3,62,65,66
. Levels of ATF4 are shown to 
increase in response to several stressful stimuli including ER and oxidative stress, 
hypoxia, and amino acid deficiency
3,67–69
. ATF4 mRNA contains three initiator 
methionine residues, only one of which yields a functional protein. Translation of ATF4 
mRNA is thus regulated by two upstream open reading frames (uORFs) and is dependent 
on the efficiency of the translational machinery (Fig. 1.2A)
34,63
. Initiation and translation 
using the first ATF4 uORF (uORF1), gives rise to a short non-functional peptide and 
facilitates ribosomal re-initiation at the downstream ATF4 uORF2. This second uORF of 
the ATF4 transcript is inhibitory as it overlaps with the start codon of the actual ATF4 
ORF but is out of frame
39,63,64
. During non-stressed states, levels of activated eIF2-GTP-
Met-tRNAi (initiator methionines) are plentiful. When scanning ribosomal pre-initiation 
complexes reach ATF4 uORF2 and are able to acquire an initiator methionine, initiation 
occurs at uORF2 and therefore translation of the ATF4 ORF is prevented (Fig. 1.2B). 
8 
 
Under states of stress leading to the phosphorylation of eIF2, decreased abundance of 
eIF2-GTP-initiator methionine results in the delay of scanning ribosomes becoming 
competent, bypassing the inhibitory ATF4 uORF2, and instead facilitate ribosome 
initiation at the ATF4 ORF to produce functional ATF4
34,63,70
. 
Pro-survivial functions of ATF4 include the increased expression of molecular 
chaperones and antioxidant species to reduce ER stress
21,62
 and increased nutrient uptake 
during starvation or amino acid deficiency by increasing gene expression of amino acid 
transporters
3,41,69,71
. Conversely, ATF4 is shown to increase the gene expression of 
downstream pro-apoptotic factors such as the C/EBP homologous protein (CHOP), also 
known as growth arrest and DNA damage-inducible gene 153 (GADD153)
39,72,73
. CHOP 
is a 29 kilodalton transcription factor consisting of a bZIP DNA binding motif
74
 that 
regulates a variety of genes involved in immune functions, cell differentiation, 
proliferation, and apoptosis
72
. The upregulation of CHOP leads to differential expression 
of effectors involved in apoptosis, namely those within the B cell lymphoma-2 (Bcl-2) 
family of proteins that consists of pro- and anti-apoptotic members
75
, as well as other 
apoptotic targets
76,77
. CHOP increases the transcription of pro-apoptotic factors such as 
BIM and PUMA during ER dysfunction
78–81
, and down-regulates the expression of anti-
apoptotic proteins such as Bcl-2
13,80
. This in turn leads to ER stress-activated caspase 
cascades such as the cleavage of executioner caspases including caspases 3 and 12 that 
ultimately lead to cell death
21
. 
ATF4-CHOP mediated apoptosis is linked to a number of diseases such as Parkinson’s 
disease, through increased neuronal death
82
, and diabetes
83
. In addition, ATF4 is 
observed to be present at much higher levels in tumors
62
 and CHOP expression has been 
associated in the development of sarcomas
84–86
, increasing the complexity of the 
physiological functions mediated by these two factors. While inhibition of translation 
during ER stress can lead to the activation of the ATF4-CHOP pathway, less is known 
about the molecular switches involved in the destiny of cells towards recovery or death. 
Thus, the response to stress is multifaceted and may involve other molecular components 
and pathways yet to be elucidated. 
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As mentioned previously, the IRE1 branch of the UPR has stress-adaptive functions, such 
as increase in chaperone expression to drive greater protein folding and/or the 
degradation of misfolded proteins to reduce ER protein load. However, IRE1 has also 
been shown to regulate apoptosis through its interaction with cytoplasmic partners and 
kinases to alter cellular levels of anti- and pro-apoptotic factors. Several studies show this 
primarily occurs through the formation of a multi-component complex with IRE1, 
ultimately leading to the activation of executioner caspases that carry out the destruction 
of cells. Interaction of the cytoplasmic domain of IRE1 with the adaptor protein, tumor 
necrosis factor receptor-associated factor 2 (TRAF2), leads to IRE1 coupling with the 
plasma membrane death receptor tumor necrosis factor receptor 1 (TNFR1) and apoptosis 
signal-regulating kinase 1 (ASK1). This complex then activates c-Jun N-terminal kinases 
(JNK), leading to downstream activation of caspases and results in cell death
11,13,43
. 
Furthermore, the RIDD activity of IRE1 has been found to reduce levels of micro-RNA 
precursors that normally function to increase the expression of respective micro-RNAs 
that are responsible for repressing the translation of caspases
47
. Thus, the activities of 
IRE1 provide another mechanism in addition to the PERK-ATF4-CHOP mediated 
apoptotic pathway that may contribute to a pro-apoptotic response during cell stress. 
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Figure 1.2. Regulation of ATF4 mRNA translation. (A) Diagram of the mammalian 
ATF4 mRNA transcript showing the sequence motifs involved in regulating the 
production of functional ATF4 encoded by its open reading frame (ATF4 ORF). ATF4 
has three initiation start sites, represented by the black arrows. Translation of ATF4 is 
mainly regulated by the second upstream open reading frame (uORF2) as it overlaps with 
the start codon (AUG) of the main coding region of ATF4 and is out of frame. (B) Under 
non-stressed conditions where normal eIF2-eIF2B guanine nucleotide exchange activity 
occurs, once scanning ribosomes reach the AUG of uORF2 and acquire an eIF2-GTP-
Met-tRNAi to initiate there, it bypasses the initiation start site of the ATF4 ORF, and 
therefore ATF4 translation is prevented. Under stressed conditions with lowered levels of 
activated eIF2, scanning ribosomes do not acquire an eIF2-GTP ternary complex in time 
and downstream initiation sites are preferentially used, such as the ATF4 ORF, resulting 
in the increased levels of ATF4 translation. 
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1.3 Other cellular stress pathways and in vitro models of 
stress 
As mentioned previously, a wide range of stressful stimuli exists that can be damaging 
and destructive to cells. Often these stresses converge to affect the integrity and 
functionality of macromolecules such as proteins and DNA or cause imbalance of 
important ions and organic compounds such as lipids, co-factors, essential amino acids, 
and metabolites. Experimentally induced forms of cellular stress that interfere with these 
macromolecules or cellular processes have been widely studied through the use of 
physical, biological, and pharmacological stressors that model stress-related pathological 
states and diseases. 
Oxidative stress for example is a well-studied form of stress that occurs as a result of an 
increase in reactive oxygen species (ROS). These include damaging radical species such 
as hydroxyl radicals (•OH) and superoxide radicals (O2•
−
) that result from the homolytic 
covalent bond cleavage of oxygen and peroxides that exists in cells
87
. These radicals can 
then go on to damage biomolecules such as proteins
88
, lipids
89
, and nucleic acids
90
, 
resulting in cellular stress and dysfunction. Consequences of oxidative stress have been 
linked to several diseases such as hyperglycemia and diabetes, Alzheimer’s, and 
cancer
87,91
. Imbalances in pro-oxidant and anti-oxidant species, such as the major anti-
oxidant glutathionine, can also lead to the production of such damaging molecules and 
disrupt the redox status of cells
87
.  This can be imposed by toxins found in the 
environment such as cigarette smoke or deprivation of minerals or vitamins as a result of 
malnutrition or starvation that are needed as cofactors for the activity of enzymes to 
prevent the production of ROS
91
. In vitro models of oxidative stress often use 
pharmacological methods such as treatment with hydrogen peroxide
87
, arsenite
92
, and 
rotenone
93
 to induce the production of ROS and study downstream effects. 
Stimuli leading to the disruption of protein synthesis, structure, and function represent 
another widely studied model of cellular stress. Thermal stress via heat shock can 
denature proteins that can lead to toxic aggregates if not recognized and removed by 
degradation machinery
94–96
. Treatment with tunicamycin has been used in several studies 
to prevent the glycosylation of essential proteins within the endoplasmic reticulum (ER) 
13 
 
and Golgi apparatus to induce protein stress
97
. It does so by inhibiting the enzyme N-
acetylglucosamine (GlcNAc) phosphotransferase (GPT) to prevent the transfer of a 
GlcNAc-1-phosphate on a UDP-GlcNAc molecule to a dolichol phosphate, thereby 
blocking the linkage of glycan molecules to asparagine residues of proteins
98–100
. The 
formation of disulfide bond linkages and the glycosylation of proteins are highly 
important with respect to the stabilities of proteins likely to be exposed to harsher 
extracellular conditions, such as secretory and cell surface proteins
9
. Stresses such as 
ischemia and malnutrition can affect proper glycosylation of proteins in the ER, leading 
to ER stress
101
. ER stress as a result of the disruption in protein glycosylation has been 
linked to diseases such as diabetes
100,102
, development of receptor-mediated 
carcinomas
103,104
, muscular dystrophies
105
, and a set of pathologies grouped under 
congenital disorders of glycosylation (CDGs)
102,106
. Thus the use of tunicamycin within 
the experiments presented in this thesis allows us to model physiological stresses linked 
to disruption in protein glycosylation and study stress response in cells. 
Other stressors often used to experimentally induce cellular stress and disrupt functions 
of the ER include thapisgargin, which is a sarcoplasmic-endoplasmic reticulum calcium-
ATPase inhibitor that raises cytosolic calcium ions concentrations by blocking the re-
uptake of these ions back into the ER
107
. This would result in ER stress and the depletion 
of intracellular calcium stores leading to downstream deficiency of calcium ions
108
. 
Furthermore, the maintenance of high cytosolic concentrations of calcium can lead to 
aberrant cellular signalling mediated by calcium-dependent pathways, many of which 
regulate proper cardiovascular physiology
13,23,24
. Lastly, staurosporine is also used to 
induce stress in various cell lines as a potent non-specific inhibitor of protein kinases
109
 
and is known to activate apoptosis through both caspase-dependent and caspase-
independent mechanisms
110
. These methods to experimentally induce cellular stress are 
invaluable as they allow us to gain a better understanding of the biochemical processes 
and the molecular components involved in stress and stress response. 
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1.4 Regulation of protein synthesis: Translational control at 
initiation 
The process of protein synthesis, or translation of an mRNA transcript, is a highly 
energetic process that involves three major steps: initiation, elongation, and termination. 
Regulation of protein synthesis is important to prevent aberrant protein load. Translation 
is principally regulated at the initiation stage to allow rapid, spatial control of gene 
expression
34
. Initiation is the rate-limiting step in protein synthesis and is affected by 
properties of the mRNA transcripts themselves, the ribosomal machinery, several 
different enzymes and a family of proteins referred to as eukaryotic initiation factors 
(eIFs)
111–113
, where the dyregulation in any of these components can contribute to 
diseases related with protein stress
59,60
. 
The majority of proteins are translated via a “scanning” mechanism that begins at the 
most proximal region of an mRNA via recruitment of the 43S pre-initiation complex, 
composed of a 40S small ribosomal subunit and eIFs, to the 5’ guanosine cap. In 
mammals, nine different eIFs are required to begin translation, and importantly, activated 
eIF2 brings the initiator methionine to the start codon, which is usually the first AUG of 
an mRNA transcript
34
. As the ribosomal pre-initiation complex moves along and scans 
the transcript in 5’ to 3’ fashion, acquisition of an eIF2-GTP-Met-tRNAi base pairs with 
the triplet codon sequence within  the open reading frame of the target gene. This is 
followed by the recruitment of a 60S large ribosomal subunit to form a complete, 
elongation-competent, 80S ribosomal complex that initiates and proceeds to translate the 
mRNA
34,63,70
. Addition of sequential amino acids to the growing peptide via specific 
tRNA molecule anti-codon base pairing to codons of the mRNA sequence occurs during 
elongation. This continues until a stop codon is reached, terminating protein synthesis 
and the dissociation of the ribosomal components to release the formed peptide chain. 
1.4.1 Translational control by eukaryotic initiation factor 2 (eIF2) 
As mentioned previously, protein translational control can occur as a result of the 
phosphorylation of eIF2. eIF2 is a heterotrimeric GTPase that is made up of an α, β, and 
γ-subunit111. The γ-subunit contain the guanine nucleotide binding domain and has also 
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been shown to be the site of binding for initiator methionine (Met-tRNAi)
111. Both the β-
subunit and the α-subunit of eIF2 are sites that are involved in the regulation of initiation 
of protein synthesis. At the end of initiation, GTP bound to eIF2 is hydrolyzed to GDP 
and eIF2-GDP is released from the ribosome. Another eukaryotic initiation factor, eIF2B, 
is a heteropentameric guanine nucleotide exchange factor (GEF) that catalyzes the 
exchange of GDP for GTP on eIF2, thereby reconstitutes eIF2-GTP that is capable for 
another round of translation initiation (Fig. 1.3)
113,114
. The interaction between eIF2 and 
eIF2B occurs at the C-terminus of the β-subunit of eIF2 (eIF2β) and the ε-subunit of 
eIF2B (eIF2Bε)111. Serine residue 51 of the α-subunit of eIF2 (eIF2α) is the site of 
phosphorylation targeted by various stress-activated kinases. During ER stress, the 
phosphorylation of eIF2α (p-eIF2α) by activated PERK increases eIF2 binding affinity to 
eIF2B, thereby blocking its GTP-exchange activity
35,115–118
. Furthermore, the stable 
complex between eIF2 and eIF2B reduces the amount of available eIF2B for the 
reformation of eIF2-GTP and thereby impedes initiation, resulting in global translation 
inhibition (Fig. 1.3)
113
. In mammals, three other kinases activated by different stress 
stimuli converge to phosphorylate eIF2α. These include the general control non-
derepressible 2 (GCN2) kinase, activated upon deficiency in essential amino acids
69,119
; 
protein kinase RNA-activated (PKR) kinase, activated during the presence of double-
stranded RNA from viral infection
118,120
; and heme-regulated inhibitory (HRI) kinase, 
activated during heme deficiency, oxidative stress, osmotic and heat shock
120,121
. 
Regardless of the type of stress initially imposed, the fact that they all converge to 
phosphorylate eIF2α demonstrates the importance in the regulation of initiation of 
translation in response to stress. 
The transient inhibition of protein synthesis can be considered beneficial during times of 
stress as it allows for the conservation of energy and the allocation of resources focusing 
on recovery pathways for cell survival
27,29,122
. However, as discussed above,
 
the 
inhibition of initiation as a result of reduced eIF2-GTP can lead to the upregulation of 
factors such as ATF4 that mediate apoptosis. Additionally, prolonged inhibition of 
translation can lead to the depletion of necessary proteins for other physiological 
functions or maintenance of cell integrity. The growth arrest and DNA damage-inducible 
16 
 
protein (GADD34) associates with protein phosphatase 1 (PP1) to promote 
dephosphorylation of eIF2α123 and re-establish normal translational activity. 
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Figure 1.3. Factors involved in regulating translation. Activated eIF2 (eIF2-GTP-Met-
tRNAi) brings the initiator methionine to the start codon of an mRNA transcript, a 
requisite step to initiate translation, followed by GTP hydrolysis catalyzed by eukaryotic 
initiation factor 5 (eIF5) to begin the process of protein synthesis. Activity of the guanine 
nucleotide exchange factor, eukaryotic initiation factor 2B (eIF2B), reconstitutes eIF2-
GTP to continue the cycle of translation. During times of stress, the α-subunit of eIF2 
gets phosphorylated by various stress activated kinases which leads to greater binding 
affinity of eIF2 to eIF2B. eIF2 becomes a competitive inhibitor of eIF2B, preventing its 
GTP exchange activity, thereby inhibiting translation initiation as a result of reduced 
amounts of activated eIF2. 
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1.4.2 Alternative translational mechanisms 
In addition to a regular translational start site, some transcripts contain additional AUG 
sequences upstream of the open reading frame of the protein coding region. These may 
facilitate or repress subsequent re-initiation at downstream AUG  sequences, depending 
on the efficiency in the formation of functional ribosomal initiation complexes
113
. In 
mammals, about 45-50% of genes encode mRNAs that have at least one short upstream 
open reading frame that typically reduces translation at the main open reading frame
34
, 
and lead to various functional isoforms of a protein. In addition, eukaryotic initiation 
factor 5 (eIF5) catalyzes GTP hydrolysis of eIF2 only when it is bound to a ribosomal 
initiation complex to initiate translation, and therefore could also be a site to regulate 
initiation
111,124
. Other ways that the processes of translation of target genes can be 
regulated include the modification of the 5’ cap structure or polyadenylation tail of 
mRNAs, which are normally strong promoters for the recruitment of eukaryotic initiation 
factors to initiate translation. 
During reduced translation as a result of eIF2α phosphorylation under times of stress, the 
increased synthesis of particular mRNAs can occur through alternative translation 
mechanisms, such as the use of internal ribosome-entry sequences (IRESs), which 
mediate 5’ cap-independent translation initiation. IRESs within mRNA directly recruit 
ribosomes and bypass the need to acquire all the initiation factors normally required to 
start scanning-dependent initiation at the cap
28,113,125
. Leaky ribosome scanning is another 
alternative way for translation to occur, where this usually happens when an mRNA 
molecule has a poorly defined start site, such as the lack of proper Kozak sequence, and 
contain multiple AUG sequences along the transcript where a ribosome can initiate when 
it acquires a Met-tRNAi
126
. Regardless of the mechanism, these pathways provide an 
alternative way for protein expression of selective factors during times of reduced 
translation in response to stress. 
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1.5 G protein coupled receptor (GPCR) mediated signalling 
and function in cellular stress 
Receptor-mediated stress signalling is known to drive both pathways in cell recovery and 
programmed cell death by regulating multiple response pathways that in turn determine 
cellular function and outcome
127–129
. Unregulated signals are also linked to pathologies 
and the progression of disease. G protein coupled receptors (GPCRs) are the largest 
family of transmembrane receptors involved in virtually every physiological 
process
130,131
. As such, it is well known that aberrant GPCR signalling can lead to a 
variety of disease states, and perturbation upstream or downstream of GPCRs and their 
signalling pathways can exacerbate pathophysiological states
128,131–135
. 
GPCRs serve a wide array of physiological and pathological roles mediating the 
transduction of extracellular signals into intracellular effector pathways upon activation 
by various ligands including hormones, neurotransmitters, chemokines, and 
pharmacological compounds
136
. Intracellular responses include the activation of G 
proteins and their target effector proteins which in turn control intracellular levels of ions 
and second messengers
137
. The specific effects resulting from the activation of a GPCR 
are largely dependent on the heterotrimeric GTP binding proteins (G proteins) to which it 
is associated. Heterotrimeric G proteins consist of three subunits: α, β, and γ, each with 
several different functional isoforms identified
138
. There have been 23 different Gα 
subunit isoforms identified and these are grouped into four subfamilies: Gαs, Gαi/o, 
Gαq/11, and Gα12/13136,138.  Gαs stimulates the activity of adenylyl cyclases (AC) to 
increase intracellular cyclic adenosine monophosphate (cAMP) levels, which is an 
important second messenger that acts to amplify the signal and can regulate the activity 
of downstream proteins in the signalling cascade such as kinases and ion channels
139
. In 
contrast to Gαs, Gαi/o inhibits AC and thereby decreases cAMP levels139, as well as 
regulating other effectors. The primary effect of Gαq/11 activity is the activation of the 
enzyme phospholipase Cβ, which leads to the increase of intracellular inositol 
triphosphates (IP3) and diacylglycerol (DAG) upon cleavage of the membrane-bound 
phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2). This further acts to regulate 
Ca
2+
 levels and the activation of protein kinase C
140. Studies show that Gα12/13 regulates 
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cellular processes through the use of guanine nucleotide exchange factors such as Rho 
proteins that further activate Rho-dependent kinases and play a role in cytoskeleton 
remodelling and cell migration
141
. 
As mentioned above, dysfunctional GPCRs are linked to diseases such as retinitis 
pigmentosa, nephrogenic diabetes insipidus, obesity, cardiovascular disease, asthma, and 
several others
128
. Thus, the regulation of GPCR and G protein activities and functions are 
essential to maintain proper organismal physiology and survival. 
1.6 Regulator of G protein signalling (RGS) proteins 
Several accessory proteins have been identified that modulate GPCR signalling and 
function
142–146
, one of which is a family of small proteins known as the regulator of G 
protein signalling (RGS) proteins. RGS proteins are a family of GTPase accelerating 
proteins (GAPs) that contain a conserved 120 amino acid RGS domain that decreases 
GPCR-mediated signalling by increasing the rate of hydrolysis of GTP bound to Gα 
subunits, thereby inhibiting signaling and activation of downstream effectors (Fig. 
1.4)
142,143
. To date, twenty distinct genes for RGS proteins have been identified in 
mammals (RGS1 through 21, with the exclusion of 15), and these are further categorized 
into four subfamilies (R4/B, RZ/A, R7/C, and R12/D)
142,147
. In addition, there are 
approximately twenty related “RGS-like” proteins that are structurally diverse and have 
some GAP functions
147. All RGS proteins serve as GAPs for Gαi/o while some can also 
act on Gαq/11 proteins130,148. So far, none of these RGS proteins appear to affect the rate 
of GTP hydrolysis of either Gαs or Gα12/13 subfamily of proteins130, however there is 
evidence for the mediation of Gαs signalling by RGS proteins through affecting its 
effector adenylyl cyclases and/or direct binding to Gαs149–153. Furthermore, different RGS 
proteins have been shown to have selective GAP activity to different Gα isoforms. In 
particular, regulator of G protein signalling 2 (RGS2) has been shown to have low 
affinity for Gαi/o inhibition and thus preferentially acts on Gαq/11154–156. A number of 
studies also show that RGS proteins can attenuate GPCR signalling via interaction with 
downstream effectors and other regulatory components
142,149
, and have roles outside of 
their effects on G protein signalling
142,157–160
, further demonstrating their importance in 
cellular physiology. 
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Figure 1.4. Regulation of G protein coupled receptor (GPCR)-mediated activity by 
regulator of G protein signalling (RGS) proteins. Heterotrimeric G proteins govern the 
specific cellular effects upon activation of GPCRs. RGS proteins attenuate GPCR 
signalling by binding to Gα subunits and increasing the intrinsic GTP hydrolytic activity 
of Gα. Hydrolysis of GTP inactivates Gα and is thought to promote re-association with 
Gβγ, thereby turning off both Gα and Gβγ signalling effects. A set of proteins known as 
guanine nucleotide exchange factors (GEFs) mediate the GDP-GTP exchange on Gα 
leading to its reactivation and allowing receptor-mediated signalling and functions. 
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1.7 Regulator of G protein signalling 2 (RGS2) 
1.7.1 Cellular functions of RGS2 and modulation of GPCR 
signalling 
As mentioned previously, the regulation of protein synthesis and folding is important for 
their functionality and to prevent cell stress and associated pathologies. RGS2 is a 
member of the RGS family of proteins that appears to play an important role in cellular 
stress responses
159
. RGS2 belongs to the R4/B subfamily of RGS proteins which consists 
of small (20-30 kilodalton) proteins with short, simple N- and C-termini flanking the 
conserved RGS domain (Fig. 1.5A)
142,160,161
. The N-terminal domain of RGS2 has been 
shown to be important in the recruitment and binding of RGS2 to GPCRs to inhibit 
receptor and G protein-mediated signalling
162,163
. 
RGS2 is unique in the fact that it has relatively low binding affinity for Gαi/o proteins 
and therefore selectively attenuates Gαq/11-mediated signals to a greater extent than all 
other RGS proteins within this family
155
. Interestingly, we and others have demonstrated 
the ability of RGS2 to inhibit cAMP production facilitated by Gαs activation through a 
GAP-independent manner
150,164
. This is likely through its ability to bind and  interact with 
Gαs and adenylyl cyclases149–151, providing evidence of the ability of RGS2 to attenuate 
Gαs-mediated effects and to have functions apart from its GAP activity. 
Gαq/11 is associated with several types of GPCRs, many of which are known to be 
important in the regulation of cardiomyocyte structure and function
127,136
. These include 
GPCRs such as endothelin-1, angiotensin II, M3 muscarinic, and α1-adrenergic 
receptors
127
, of which many show enhanced activity and result in pathological phenotypes 
such as hypertrophy of cardiomyocytes and increased susceptibility to atrial arrhythmia 
in mice lacking RGS2
165–167
. Additionally, in vitro studies show that the loss of 
endogenous RGS2 can exacerbate hypertrophic Gαq/11-mediated signalling168. Gαq/11 
signalling has also been shown to activate particular protein kinases, such as members of 
the mitogen-activated protein kinase (MAPK) family and protein kinase B (Akt/PKB)
169
, 
which are known to be induced by various stress signals ranging from inflammatory 
cytokines, osmotic stress, and heat shock
170
. These kinases are involved in cell stress 
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response and depending on the particular kinase activated, it may mediate cell survival, 
such as Akt/PKB
171
, or regulate apoptotic pathways, such as JNK
172
. The activation of 
some MAP kinases are also linked to cellular hypertrophy, such as extracellular signal 
regulated kinase 1 and 2 (ERK1/2), JNK, and p38
127
. RGS proteins are known to govern 
the effects of GPCRs on MAPK signalling pathways such as ERK1/2
154,173,174
, JNK
175
, 
and p38
167,169,176
. In fact, in vitro studies conducted in our lab show that overexpression of 
RGS2 can attenuate agonist-induced cellular hypertrophy mediated by both Gαq/11167 
and Gαs166 signalling and also attenuate ERK1/2 and Akt activation which may 
contribute to its antihypertrophic effects
166,167
. Paradoxically, a study showed that the 
upregulation of RGS2 by ischemia lead to greater cell death in astrocytes and these 
effects were abolished upon the use of a p38 MAPK inhibitor
177
. This suggests a possible 
synergistic or feedback mechanism between MAP kinase activation and RGS2 
expression. The relative contribution of various pathways of the MAPK system on stress 
response and how these are affected by RGS2 is not well understood. Since many of 
these stimuli also induce ER stress and ER-initiated apoptosis, RGS2 may be an adaptive 
protein in stress response. These collective findings suggest protective roles of RGS2 in 
cell stress, however, the molecular mechanisms regulating these responses is not well 
known and therefore this was investigated in the studies contained in this thesis. 
 
 
 
 
 
 
 
 
24 
 
 
 
 
 
 
 
 
Figure 1.5. Schematic of the domains governing functions of RGS2. (A) Diagram of 
the full-length 211 amino acids RGS2 protein. Amino acid residues 79 to 199 house the 
functional GTPase accelerating domain conserved in all RGS proteins. Within this 120 
amino acids RGS domain, the short 37 amino acids domain (residues 79 to 116) is 
determined to be the region mediating the binding of RGS2 to eIF2Bε to inhibit protein 
synthesis. (B) Comparison of the sequence homology between the established eIF2Bε-
interacting domain of eIF2 (eIF2β) and the RGS2 eIF2Bε-binding domain (Nguyen et al., 
2009). 
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1.7.2 Distribution and regulation of RGS2 expression 
RGS2 is ubiquitously expressed in all tissues throughout the body, with the mRNA 
detected in organs such as the heart, brain, lungs, and kidneys, as well as in cell types 
including pre-adipocytes, vascular smooth muscle cells, osteoblasts, immune cells, and 
chondrocytes at moderate to high amounts
178–181
. Stress stimuli can activate GPCRs, and 
agonist-induced Gαq/11 and Gαs signalling is shown to selectively upregulate RGS2 in 
cardiomyocytes but not other R4/B RGS proteins
166,167
, demonstrating the functional 
importance of RGS2 in providing a feedback mechanism to regulate G protein 
signalling
182
. Furthermore, the expression of RGS2 is upregulated by several forms of 
stress including heat shock
159,183
, bacterial infection
184
, DNA damage
185
, oxidative 
stress
186
, and ischemia
177
. This suggests that RGS2 may be an important component in 
cellular stress response, however the specific outcomes mediated by RGS2 are not well 
known and were assessed in the studies presented in this thesis. 
1.7.3 Physiological roles of RGS2 
Dysregulation of G protein activity can lead to aberrant signalling and lead to stress 
within tissues that may ultimately lead to disease. RGS2-knockout mice have greater 
susceptibility to the development of atrial arrhythmias
165
, are hypertensive, and show 
greater cardiac hypertrophy in response to pressure overload
168,187
. RGS2 also plays a 
role in hypertension
161,188,189
 and anxiety
190
 in humans. RGS2 mRNA expression levels 
are shown to be significantly lower in some groups of hypertensive patients, attributing to 
decreased modulation of G protein signals known to be involved in regulating vascular 
tone
189
. Several RGS2 gene polymorphisms have been identified within patients with 
panic disorders and thus RGS2 may play a role in the development of axiety
190
.  In 
addition, RGS2-deficient mice exhibit a lean phenotype, where they have greatly reduced 
fat stores and do not develop age-related obesity as seen in wild-type counterparts
191
. 
RGS2 has also been shown to regulate the differentiation of various cell types including 
adipocytes
192
, chondrocytes
193
, myeloid cells
194
, and cell types within the pituitary
195
. 
Other RGS2 loss-of-function phenotypes include abnormal renal solute handling
196
, 
decreased T-cell proliferation and antiviral immunity
197
. As a result of the broad tissue 
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distribution of RGS2 throughout the body, changes in RGS2 expression or activity would 
be expected to have profound physiological effects. 
1.7.4 Translational control by RGS2: Role of RGS2 in cellular 
stress response 
Recent work on the functional molecular biology of RGS2 has shown its ability to affect 
translational machinery, suggesting novel functions of RGS2 distinct from its known 
roles as a negative modulator of G protein signalling. We previously discovered a 37 
amino acid binding domain (herein termed RGS2
eb
) found at residue 79 to 116 within the 
conserved RGS domain that can bind to the epsilon subunit of eIF2B (eIF2Bε) and inhibit 
translation (Fig. 1.5A)
160
. Binding of RGS2
eb
 to eIF2Bε interferes with the eIF2-eIF2B 
GTP exchange cycle, preventing the formation of eIF2-GTP-Met-tRNAi required in the 
initiation of mRNA translation, and leads to global reduction of protein synthesis (Fig. 
1.6A). 
As discussed previously, a similar interaction occurs with eIF2β and eIF2Bε, preventing 
the GDP-GTP exchange on eIF2, thereby preventing translation at initiation. This is 
heightened under states of stress as a result of the phosphorylation of eIF2α to regulate 
protein synthesis. RGS2
eb
 and the established eIF2Bε-interacting domain of eIF2β show 
35% sequence similarity (Fig. 1.5B), while corresponding sequence comparisons with 
other RGS and RGS-like proteins did not show the same degree of similarity
160,198
. 
Furthermore, this activity of RGS2 to inhibit translation is independent of its effects on G 
proteins.  We have shown that a point mutation in the critical contact point between 
RGS2 and Gα subunits by the replacement of asparagine residue 149 to an alanine or the 
removal of a substantial portion of the RGS2 domain within the carboxy terminus of the 
protein, was not able to increase agonist-induced GTP hydrolysis but was still able to 
prevent de novo protein synthesis
160
. It is therefore hypothesized that RGS2 may compete 
with eIF2 for the binding of eIF2B, and may be an important target in the modulation of 
stress-mediated translational control mechanisms and downstream effector pathways 
affected by the cellular state of translation. Furthermore, infections using adenoviruses to 
overexpress both full length RGS2 and RGS2
eb
 have been shown to inhibit de novo 
protein synthesis in multiple cell types
160
 and to block agonist-induced cellular 
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hypertrophy
134,159
. Decreasing protein synthesis reduces protein misfolding while 
conserving cellular resources
24,29,122
, suggesting a protective role by RGS2 in cell 
stress
159,160
. This would be beneficial to prevent diseases associated with protein stress, 
such as pathological hypertrophy, and may augment the effects of stress-activated 
kinases
159,199
. Additionally, RGS2 may provide an alternative way in regulating 
translation independent of eIF2α phosphorylation during stress (Fig. 1.6B). However, the 
full benefit of this is questionable as inhibition of translation can drive pathways leading 
to cell death, such as that mediated by the ATF4-CHOP pathway. How these effects by 
RGS2 modulate components of the UPR and apoptosis was therefore assessed in this 
thesis. 
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Figure 1.6. Mechanism of translational control by RGS2. (A) Binding of RGS2 to the 
ε-subunit of eIF2B prevents the necessary GDP-GTP exchange of eIF2, thereby 
preventing initiation of mRNA translation and the reduction of global protein synthesis. 
(B) Schematic of pathways involved in the unfolded protein response and the putative 
role that RGS2 may have in modulating the expression of endpoints associated in 
response to cell stress (highlighted in pink). 
A 
B 
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1.8 Rationale 
RGS2 is upregulated by many of the same forms of stress that trigger eIF2 
phosphorylation to reduce protein synthesis, suggesting that it may be an important 
modulator in stress response pathways and drive physiological outcomes. Apart from the 
GAP functions of RGS2 in regulating GPCR and G protein mediated-signalling, RGS2 
can interfere with the translational machinery to inhibit initiation, and this has been 
mapped to a short 37 amino acid eIF2Bε-binding domain (RGS2eb). Inhibition of protein 
synthesis is a hallmark response mediated by the UPR in order to alleviate stress. The 
benefit of this, however, is diminished by the fact that inhibition of initiation can result in 
the preferential upregulation of pro-apoptotic pathways. Furthermore, the expression of 
several proteins involved in such pathways are controlled by alternative translation 
mechanisms, triggered by eIF2α phosphorylation, and it is unclear whether the inhibitory 
effects on protein synthesis of RGS2 may provide a parallel pathway and drive similar 
outcomes during stress. Therefore, to better understand how the translational control 
abilities of RGS2 may contribute to the cellular stress response, we investigated its roles 
in relevant pathways, as outlined by the specific objectives below. 
1.8.1 Hypothesis and Predictions 
We hypothesized that RGS2 contributes to the cell stress response through its 
translational control abilities. We predicted that RGS2 would promote alternative 
translation and thereby affect the expression of factors involved in the unfolded protein 
response. 
1.8.2 Objectives 
It is well established that the phosphorylation of eIF2α by various stress-activated kinases 
inhibits initiation of mRNA translation and promotes expression of particular stress 
proteins through alternative translation mechanisms
34,64,117,200,201
. The inhibitory effects of 
RGS2 on protein synthesis, more specifically through its eIF2Bε-binding domain 
(RGS2
eb
), perhaps provide a complementary pathway to prolong reduced translation 
during stress once dephosphorylation of eIF2α begins202. Whether this effect by RGS2 
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can promote alternative translation in a similar manner mediated by the phosphorylation 
of eIF2α is not known leading to my first research objective: 
1. To determine the effect of RGS2 and RGS2eb on alternative translation 
mechanisms. 
This was directly investigated using cell based assays assessing the effect of RGS2 on the 
expression of stress-response proteins controlled by alternative translation mechanisms, 
such as ATF4. We expected that there would be enhanced expression of such protein if 
the inhibitory effects of RGS2 on translation do indeed promote alternative translation 
and thus may also affect cell stress response. 
Key features of the cellular stress response include the regulation of the expression and/or 
the activity of stress-adaptive factors, or the induction of apoptosis should recovery be 
unsuccessful
29,117,203,204
. Whether the inhibitory effects of RGS2 on translation influence 
either of these facets of the stress response and the underlying mechanisms by which this 
occurs is not well understood, leading to the two other objectives of my research assessed 
in this thesis: 
2. To determine the effects of RGS2 expression on the translational and 
transcriptional profiles of endpoints of the UPR during cell stress. 
3. To determine the effects of RGS2 on stress-induced apoptosis. 
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Chapter 2  
2 Materials and Methods 
2.1 Cell culture 
NIH-3T3, a well-established murine fibroblast cell line, were used to assess the effects of 
RGS2 expression on cellular stress and apoptosis. In addition to previously published 
studies looking at apoptosis in this cell line
205
, preliminary studies in our lab have shown 
that NIH-3T3 fibroblasts overexpressing RGS2 resulted in the activation of caspase 3 
after experimentally-induced stress. Other commonly used cell lines such as HEK-293 
(human embryonic kidney cells) were also tested but did not appear to have any effect 
(unpublished data). Therefore, NIH-3T3 was chosen as the cellular model to assess our 
research questions on the effects of RGS2 expression in stress response pathways. NIH-
3T3 cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM, Gibco Life 
Technologies) supplemented with 10% (v/v) fetal bovine serum (FBS, Gibco Life 
Technologies) at 37°C with 5% CO2. 
2.2 Adenoviruses 
Recombinant adenoviruses, viral propagation, titre and multiplicity of infection 
determination 
Replication-defective adenoviruses encoding GFP (Ad-GFP), full-length His6-tagged 
human RGS2 (Ad-RGS2), and the His6-tagged 37 amino acid eIF2Bε binding domain of 
RGS2 (Ad-RGS2
eb
) were generated in our lab as previously described
134,160
. 
Adenoviruses were propagated in E1-producing HEK-293 cells. Briefly, cells were plated 
in 145 mm tissue culture plates in DMEM supplemented with 10% FBS, 24 hours prior to 
infection. Plates were checked and verified to be 80-90% confluent on the day of 
infection and 5 ml crude adenoviral stock was added to the cells. Cells were kept at 37°C, 
5% CO2, and infection proceeded until 80-90% of the cells had become spherical and 
detached from the plate. Adenoviruses were harvested from the cells via three freeze-
thaw cycles. Cell lysates were centrifuged at 3000 rpm for 15 minutes at room 
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temperature to pellet cell debris. Supernatant containing viral particles were transferred to 
cryovials in 1 ml aliquots and stored at -80°C. Titring of the adenoviral constructs was 
carried out following the procedures described in Franceschi and Ge (2008)
206
. Levels of 
expression of adenoviral encoded proteins were also monitored through fluorescence 
microscopy for GFP. Cell lysates were collected and immunoblotted with rabbit anti-6X 
His tag ChIP grade antibody (1:1000, Abcam ab9108), chicken anti-RGS2 antibody 
(1:1000, Sigma-Aldrich GW22245F), or mouse anti-GFP (1:1000, Clontech 632381) to 
assess viral infection and levels of protein expression, as appropriate. See Appendix A, 
Fig. A1 for representative blots assessing the multiplicity of infection (MOI) of the 
viruses in 3T3 fibroblasts. Expression of polyhistidine-tagged RGS2
eb
 in cells via 
infection using the generated recombinant adenoviral vectors was verified in previous 
studies via immunofluorescent staining and dot blot analysis of whole cell lysates
134
. 
2.3 Reagents and drugs 
Adenovirus-infected cells were subjected to stress via treatment with tunicamycin (TM), 
thapsigargin (TH), or apoptosis-inducing agents such as staurosporine (ST). Dimethyl 
sulfoxide (DMSO, 0.1% v/v) vehicle controls were run in parallel. Tunicamycin (Sigma-
Aldrich T7765) was diluted to the indicated experimental concentrations from a 10 
mg/m1 stock solution in DMSO. Staurosporine (TOCRIS Bioscience 1285) was diluted 
to the indicated concentrations from a 2 mM stock solution in DMSO. Thapsigargin 
(TOCRIS Bioscience 1138) was diluted to the indicated concentrations from a 5 mM 
stock solution in DMSO. Effective concentrations and length of time of drug treatments 
used in dose-response and time-course assays are indicated in figure legends and were 
selected as reported
42,107,207–214
. We confirmed that these stressors activated endpoints 
associated with stress response and/or apoptosis (see Appendix B, Fig. B4). Water-
soluble forskolin (7β-deacetyl-7β-(γ-N-methylpiperazino)-butyryl, dihydrochloride 
foskolin, Calbiochem, La Jolla, CA) was used to induce endogenous RGS2 expression
182
 
(see Appendix A, Fig. A3). 
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2.4 Adenoviral infection and protein isolation 
Cells were seeded in 12 well plates and grown to 60-70% confluency (approximate cell 
density of 5.8×10
5
 cells/ml) on the day of infection. Cells were infected for 48 hours with 
Ad-RGS2, Ad-RGS2
eb
, Ad-GFP (as an infection control), or left uninfected (NI), under 4 
hours of serum deprivation, after which medium was removed and replaced with 
complete cell culture medium. Infection with the adenoviruses occurred for 48 hours, 
after which cells were treated with a chemical stressor at indicated concentrations and 
durations or subjected to a vehicle control. Cell lysates were prepared by washing with 
ice-cold 1X phosphate-buffered saline (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4, pH 7.4) and scraping into 200 μl of  ice-cold lysis buffer (250 mM 
NaCl, 50 mM Tris pH 8, 5 mM EDTA, 0.5% NP-40 (IGEPAL), phenylmethylsulfonyl 
fluoride protease inhibitor tablet (Roche), 20 mM Na4P2O7, 10 mM NaF, and 20 mM 
Na3VO4). Cells were incubated in lysis buffer with rocking for 30 minutes at 4°C. Cell 
lysates were homogenized by vigorous pipetting through a 1.5 mm pipette tip followed 
by three freeze-thaw cycles with liquid nitrogen. Cell pellets were sedimented by 
centrifugation at 11 000 × g for 15 minutes at 4°C. Supernatants were collected and 
protein concentrations were determined using Pierce bicinchoninic acid (BCA) protein 
assay kit (Thermo Scientific) and protein (bovine serum albumin) standard curve 
calculations. 
2.5 Immunoblotting 
Protein samples were prepared using 5X Laemmli loading (sample) buffer (60 mM Tris-
HCl pH 6.8, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.02% bromophenol blue) 
and balanced with 1X sample buffer for equal protein concentration. Unused protein 
samples were frozen immediately and stored at -20°C. Protein samples were heated to 
99°C for 5 minutes prior to loading and gel electrophoresis. Equal amounts of protein (5 
or 10 μg per lane) were separated by 10-12% SDS-PAGE and wet transferred onto 
nitrocellulose membranes (Whatman Protran). Membranes were incubated in blocking 
buffer (Tris-buffered saline, 0.1% Tween-20, 5% skim milk) and rocked for 1 hour at 
room temperature before overnight incubation with rocking at 4°C with respective 
antibodies to assess targeted endpoint proteins associated in ER stress and cell death 
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pathways: anti-BiP/GRP78 (1:1000, Pierce PA5-17423), anti-phospho-eIF2α (1:1000, 
Cell Signaling 9721), anti-CREB-2/ATF4 (1:5000, Santa Cruz sc-200X), anti-CHOP 
(1:1000, Cell Signaling 5554), anti-cleaved caspase 3 (1:1000, Cell Signaling 9964). 
Protein lysates extracted from full-body ATF4 knockout mouse embryos (E16.5) were 
run in parallel to determine ATF4-specific protein band, indicated by black arrowheads 
on representative immunoblots. ATF4 knockout mouse embryos were generously 
provided by Dr. Sean Cregan (Robarts Research Institute, London, ON). Anti-RGS2 
(1:1000, Sigma-Aldrich GW22245F) was used to assess for endogenous and 
heterologously expressed levels of RGS2 under various stress conditions, anti-GFP 
(1:1000, Clontech 632381) and anti-6X His tag ChIP grade antibody (1:1000, Abcam 
ab9108) were used to probe for GFP and 6xHis-tagged RGS2, respectively, to assess 
adenoviral infection efficiency and expression. Purified His6-tagged RGS2 protein 
samples (50 ng) were loaded into SDS PAGE gels as a positive control for expression of 
RGS2. Membranes were then incubated for 1 hour at room temperature with appropriate 
horseradish peroxidase-conjugated secondary antibodies: anti-rabbit IgG (1:3000, Pierce 
31463), anti-mouse IgG (1:3000, Pierce 31437), or anti-chicken IgY (1:3000, Pierce 
SA1-72012). Immunoblots were visualized with SuperSignal West Pico 
chemiluminescent substrate (Thermo Scientific) and digitally imaged using Bio-Rad 
VersaDoc camera and Quantity One program (Bio-Rad, model GS-700). Immunoblots 
were stripped using Restore Western blot stripping buffer (Thermo Scientific) and re-
probed to assess total protein species of ER stress and apoptotic endpoints such as anti-
eIF2α (1:1000, Cell Signaling 9722), and anti-caspase 3 (1:1000, Cell Signaling 9665). 
Anti-β-tubulin (1:1000, Pierce PA5-16863) or anti-GAPDH (1:1000, Pierce PA1-988) 
were used to assess protein loading and were stable across experimental conditions. 
2.6 Densitometry 
Relative protein expression levels from immunoblots were quantified and analyzed by 
densitometry (Quantity One, Bio-Rad). Relative densitometric signal of target protein 
bands were determined with subtraction of background signal of immunoblots. For 
assessment of changes in caspase 3 activation, a densitometric ratio of cleaved caspase 3 
to uncleaved caspase 3 was taken. For phosphorylated proteins, densitometric ratios of 
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phosphorylated to total species were taken. Data are presented as means ± SEM where 
the level of statistical significance was set at α = 0.05. Statistical differences were further 
evaluated by post-hoc tests indicated, where p-values of <0.05 were considered 
statistically significant. All statistical analyses were performed using GraphPad Prism® 
5.01. 
2.7 RNA isolation, reverse transcription (RT-PCR), and 
quantitative polymerase chain reaction (qPCR) 
Cells were seeded in 24 well plates and grown to 60-70% confluency (approximate cell 
density of 5.8×10
5
 cells/ml) on the day of infection. Cells were infected for 48 hours with 
Ad-RGS2, Ad-RGS2
eb
, Ad-GFP (as an infection control), or left uninfected (NI), under 4 
hours of serum starved conditions then replaced with complete cell culture medium. After 
48 hours of infection, cells were treated with chemical stressors or vehicle control at the 
indicated concentrations and durations. Total RNA was then extracted from cells using 
TRIzol reagent (Invitrogen) following the manufacturer’s protocol. RNA purity and 
concentrations were quantified through spectrophotometry (NanoDrop Lite, Thermo 
Scientific). RNA samples with an absorbance ratio (A260 nm/A280 nm) of 1.8-2.2 were 
determined to be pure for use in downstream PCR applications. RNA samples (2 μg) 
were reverse transcribed (RT-PCR) to generate first strand cDNA using a High Capacity 
cDNA Reverse Transcription kit (Applied Biosystems) on a T100 Thermal Cycler 
(BioRad). Primer sets directed against target genes of interest were designed using the 
National Centre for Biotechnology Information Nucleotide sequences database 
(www.ncbi.nlm.nih.gov/nuccore) and Invitrogen’s OligoPerfect Designer primer 
designing tool (www.thermofisher.com/oligoperfect/). Primers were custom 
manufactured by and purchased from Sigma-Aldrich Custom DNA Oligos (Table 2.1). 
ATF4 primers and sequences were generously provided by Dr. Sean Cregan (Robarts 
Research Institute, London, ON). Quantitative analysis of mRNA expression levels of 
endpoints of the cellular stress response: ATF4, CHOP, BiP/GRP78, and spliced XBP1 
(XBP1s) were determined through qPCR carried out in 384 well plates using fluorescent 
nucleic acid dye SensiFAST SYBR Green No-ROX kit (Bioline) based assays, following 
manufacturer’s protocol. Reactions were carried out on CFX384 Real Time PCR 
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Detection System and analyzed using CFX Manager 3.0 program (BioRad). The cycle 
threshold was set so that exponential increases in amplification were approximately level 
between all samples at the linear phase of the amplification curves. Relative mRNA 
levels of respective target genes were quantified using standard curves generated from 
five-fold serial dilutions of pooled cDNA samples, then normalizing all values to the 
geometric means of two reference genes (GAPDH and β2 microglobulin) measured in 
parallel. Reference genes were stable across experimental conditions to allow 
comparative assessments on the relative change in the expression of targeted genes of 
interest under indicated experimental conditions. Real time data are reported as mean ± 
SEM where the levels of statistical significance were set at α = 0.05. Statistical 
differences were further evaluated by post-hoc tests indicated, where p-values of <0.05 
were considered statistically significant. All statistical analyses were performed using 
GraphPad Prism® 5.01. 
 
Table 2.1. Primers (Mus musculus) used in qPCR reactions to assess for changes in gene 
expression of stress response targets. 
Target Forward Primer Reverse Primer 
ATF4/CREB-2 
BiP/GRP78 
5’-TCTTGGACTAGAGGGGCAAA-3’ 
5’-AGTTCTTCAATGGCAAGGAG-3’ 
5’-GGGACAGATTGGATGTTGGA-3’ 
5’-ACCAAGTGTAAGGGGACAAA-3’ 
CHOP/GADD153 5’-TACACCACCACACCTGAAAG-3’ 5’-TTCTTCCTCTTCGTTTCCTG-3’ 
XBP1s 5’-GACACTGTTGCCTCTTCAGAT-3’ 5’-ACATGGTCAAAACGAATGAGT-3’ 
RGS2 5’-TGACAAATATGCCAGGTCTCTA-3’ 5’-CTGCACAGAGTGTGAGGTAAAT-3’ 
GAPDH 5’-GTTCCTACCCCCAATGTGT-3’ 5’-GGAGTTGCTGTTGAAGTCG-3’ 
β2 microglobulin 5’-ACGCAGAAAGAAATAGCAATG-3’ 5’-TGAGAAGTACAGAGGGTTTGG-3’ 
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2.8 Quantitative fluorescence microscopy reporter assay 
Sources of plasmids 
To study the putative functions that RGS2 has within cellular stress signaling, we looked 
at the effect of RGS2 overexpression on the level of BiP ER stress response element 
(ERSE) promoter activity through quantitative fluorescence microscopy. The C-
terminally FLAG-tagged human RGS2 plasmid (pcDNA3.1-hRGS2 WT-FLAG) was 
custom generated by and purchased from the Missouri S&T cDNA Resource Center 
(www.cdna.org). The BiP ERSE-tdTomato reporter construct
215,216
 was generously 
provided by Dr. Patrick Lajoie (University of Western Ontario, London, ON). pcDNA3.1 
empty vector controls were generously provided by Dr. Lina Dagnino (University of 
Western Ontario, London, ON). 
Co-transfection and quantification of the BiP ERSE promoter activity 
NIH-3T3 fibroblasts were seeded in 6 well plates and transfected with plasmids using 
Lipofectamine 2000 (Life Technologies) in reduced serum medium (Opti-MEM, Life 
Technologies) as per the manufacturer’s instructions. Briefly, each well was co-
transfected with 1 μg full-length RGS2 plasmid or 1 μg pcDNA3.1 empty vector 
backbone together with 1.25 μg BiP ERSE-tdTomato plasmid. After 24 hours of 
transfection, plates were imaged for initial baseline BiP ERSE promoter activity and 
monitored for transfection efficiency via quantitative fluorescence microscopy using a 
10x objective and 547nm excitation, 581nm emission bandpass filter for tdTomato, prior 
to any pharmacological treatment (0 hour time point). Cells were then treated with 0.1% 
DMSO (vehicle control) or 5 μg/ml tunicamycin and imaged at 1.5, 3, 6, 12, and 24 hours 
post-treatment. Co-transfections and each treatment condition were carried out in 
triplicate. At each time point, live fluorescent images from three different fields per well 
were taken using an OlympusIX71 microinjection fluorescent microscope (Olympus 
Canada) and QCapture Pro camera and software (QImaging Canada). 8-bit greyscale 
images were taken at 10x magnification to capture the tdTomtato fluorescence of a 
population of cells at each visual field. Images were then analyzed to quantify total 
fluorescence using ImageJ (National Institutes of Health, Bethesda, MD) to assess for 
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differences in the level of ERSE promoter activity across treatment conditions. 
Thresholding function on ImageJ was used to quantify the total fluorescence from the 
images, measured by the sum of all the pixels that fall within a set threshold range of 
intensity graduations. The range to capture total intensity of the tdTomato fluorescence 
from background signal (tdTomato area/pixel
2
) was set between 414 (lower threshold 
level) to 4095 (upper threshold level) which is within the linear range of signal and was 
used throughout our analyses. Areas were then multiplied by a conversion factor 
(51741.69 μm/pixel) to obtain values in tdTomato area/μm2, followed by normalization to 
the total number of cells. Cell counts from the images were performed on ImageJ by 
setting cell circularity range between 0.20 – 0.90 to determine the total number of cells 
within each visual field. All fluorescence data are reported as means ± SEM in units of 
tdTomato area/cell of three independent experiments. All statistical analyses were 
performed using GraphPad Prism® 5.01, where the level of statistical significance was 
set at α = 0.05. Statistical differences were further evaluated by post-hoc tests indicated in 
figure legends, where p-values of <0.05 were considered statistically significant. 
2.9 Statistical Analysis 
Grouped data are presented as mean ± SEM, where n represents the number of 
independent experiments. Differences between groups were determined using one-way 
ANOVA followed by Dunnett’s post-hoc test. Statistical significance in experiments 
assessing the possible effects of either the infection condition (i.e., Ad-RGS2, Ad-
RGS2
eb
, Ad-GFP, or uninfected cells) or stress treatment was determined using two-way 
ANOVA, followed by Bonferroni post-hoc tests. Between-group differences in total 
protein levels were analyzed using linear regression by constraining the y-intercept to a 
shared value for all data sets and comparing differences in the slopes of the fitted data. A 
p value < 0.05 was considered statistically significant throughout. All statistical analyses 
were performed using GraphPad Prism® 5.01. 
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Chapter 3  
3 Results 
3.1 RGS2 enhances alternative translation mechanisms 
and modulates cellular stress response pathways 
Protein synthesis is a multistep process that involves the concerted activity of many 
molecular components. From a mechanistic and energetic standpoint, the regulation of 
translation occurs right at initiation to avoid unnecessary expenditure of energy and 
resources and to allow rapid control of gene expression. The phosphorylation of the 
initiation factor, eIF2, is a well known mechanism that reduces global protein synthesis 
and integrates several stress signals of varying origins. A growing body of work also 
demonstrates the increase in cellular protein levels of specific factors under impaired 
translation which leads to different physiological outcomes in response to stress. The 
expression of many of these factors is regulated by alternative open reading frames found 
in their transcript and translated via alternative translational mechanisms described 
previously. 
Recently, we have demonstrated that the ability of RGS2 to bind and impede the 
functions of eIF2B provides another mechanism in the regulation of translation 
initiation
159,160
. This may function in parallel to the eIF2α-phosphorylation pathway to 
prolong reduced translation conditions under stress. The benefits of this are unclear, and 
whether this may modulate the expression and/or the activity of key components involved 
in the CSR was investigated. To determine whether RGS2 expression affects protein 
translation, we infected 3T3 cells with recombinant adenovirus expressing RGS2. Here, 
we show that the expression of RGS2 consistently resulted in significantly lower total 
protein concentrations, and the effect increased with the multiplicity of virus infection 
(Fig. 3.1, linear regression analysis, p = 0.0063). Cell confluency (80-90%) was 
consistent across all experimental conditions after 48 hour period of infection, assessed 
by light microscopy. This reduced the likelihood of confounding effects to our results that 
may be attributed with decreased cell number. This confirms previous findings from our 
lab on the ability of RGS2 to inhibit protein synthesis. 
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Figure 3.1. Expression of RGS2 results in reduced total cellular protein levels. 3T3 
fibroblasts were infected with RGS2 or GFP-encoding adenovirus at the indicated 
multiplicities of infection (MOI). Following 48 hours of infection, cells were lysed and 
total protein concentrations of the collected lysates were quantified as described in 
Materials and Methods. Significantly lower total protein concentrations were observed 
from lysates of RGS2 expressing cells and the effect occurred in a concentration-
dependent manner with increasing RGS2 (linear regression, p = 0.0063). Slopes of the 
fitted linear regression analysis for RGS2 (y-int = 687.40 ± 37.02, slope = -2.67 ± 0.87) 
and GFP (y-int = 687.40 ± 37.02, slope = 0.12 ± 0.87) were statistically different. Data 
presented are mean ± SEM, n = 8. 
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3.1.1 RGS2 and RGS2eb increase ATF4 and CHOP protein levels 
The expression of ATF4 is tightly regulated by the cellular state of translation and the 
efficiency of the translational machinery. During conditions of stress where the levels of 
p-eIF2α are increased, the availability of eIF2-GTP-Met-tRNAi ternary complex is 
reduced and scanning ribosomes do not acquire an initiator methionine in time to start 
translation. This delay allows ribosomes to bypass the two inhibitory upstream open 
reading frames (uORF1 and uORF2) of ATF4 and initiate translation at the ATF4 ORF 
instead to produce functional ATF4
34,70
. 
The ability of RGS2 to inhibit translation initiation has been specifically mapped to a 
stretch of 37 amino acid residues that is capable of binding to the epsilon subunit of 
eIF2B (RGS2
eb
)
160
. This binding was found to interfere with the eIF2-eIF2B GTPase 
cycle, which presumably accounts for its ability to inhibit the initiation of mRNA 
translation
160
, comparable to the inhibitory effect associated with the phosphorylation of 
eIF2α. We therefore hypothesized that the translational control abilities of RGS2 may 
affect endpoints associated in stress response, regulated by alternative translational 
mechanisms, such as ATF4. We found that ATF4 protein levels increased with increasing 
expression of RGS2 (Fig. 3.2A). This effect was not a result of the viral infection per se 
as no ATF4 was detected in corresponding GFP expressing cells. RGS2 expression 
resulted in significant cellular levels of ATF4 (two-way ANOVA, p = 0.0004), and such 
levels were observed at multiplicities of infection of 50 and 100 (Fig. 3.2B, Bonferroni 
post-hoc tests, **p < 0.01 and ***p < 0.0001, respectively). Additionally, the expression 
of CHOP significantly increased in RGS2 expressing cells (Fig. 3.2C, two-way ANOVA, 
p < 0.0001), similar to the expression pattern observed with ATF4 expression pattern. 
Interestingly, CHOP protein levels dropped at the highest level of infection. We speculate 
that this may be as a result of a saturation effect by even greater amounts of ATF4, as 
studies report that ATF4 becomes a transcriptional repressor at high concentrations
217
.  
CHOP is known to be upregulated in the stress response at the translational 
level
64,73,200,218,219
 and as well its mRNA transcription is induced by transcription factors 
including ATF2
72,220,221
, ATF4
39,72,73,222
, ATF6
223,224
, and XBP1s
45
, so multiple regulatory 
components may be involved in modulating the level of CHOP expression. 
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Figure 3.2. Dose dependent increase in ATF4 and CHOP protein levels with RGS2 
expression. 3T3 fibroblasts were infected with adenoviruses encoding GFP (viral 
infection control) or full-length RGS2 at the indicated range of multiplicity of infection 
(MOI) for 48 hours. Non-infected (NI) fibroblasts were then treated with 2 μM 
thapsigargin (TH) for 2 hours as a positive control for the induction of eIF2α 
phosphorylation and ATF4, or were treated with 0.1% DMSO (vehicle control). ATF4-
specific protein band is indicated by an arrowhead, NS = non-specific band. After 
incubation in sample buffer, proteins were separated by SDS-PAGE on two separate gels 
run in parallel. After protein transfer, membranes were cut horizontally. The top portion 
of the first membrane (approximately 40-300 kDa) was blotted with anti-ATF4, followed 
by stripping and reprobing with anti--tubulin (not shown). The bottom portion (up to 40 
kDa) was blotted with anti-CHOP. The bottom portion was then stripped and reprobed 
with anti-RGS2, followed by a second strip and reprobe with anti-GFP to assess RGS2 
and GFP expression, respectively. The top portion of the second membrane was blotted 
with anti--tubulin (shown) and the bottom portion was blotted with anti-p-eIF2α, 
followed by stripping and reprobing with anti-pan-eIFα, to assess the relative proportion 
of phosphorylated eIF2α. The same procedures were repeated for each independent 
experiment. (A) RGS2 expression significantly increased ATF4 protein levels in a dose 
dependent manner while no comparable increase was observed with GFP expressing 
cells, and this was independent of eIF2α phosphorylation. Levels of CHOP also 
significantly increased with RGS2 expression, correspondingly to the ATF4 expression 
pattern. Immunoblots shown are representative of seven independent experiments 
(thapsigargin controls were included in three of these). Corresponding densitometric data 
are summarized in bar graphs as mean ± SEM for ATF4 (B) and CHOP (C) protein 
levels. Statistical analysis was performed using two-way ANOVA followed by 
Bonferroni post-hoc test. **, Significant difference (p < 0.01). ***, Significant difference 
(p < 0.0001). For all targets assessed, immunoblotting for β-tubulin was used as the 
control for equal protein loading, here shown with one representative blot to demonstrate 
equal sample loading in our experiments (others not shown). 
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3.1.2 RGS2 and RGS2eb induce ATF4 expression without eIF2α 
phosphorylation 
The eIF2α-ATF4 axis is activated upon stress within cells and leads to changes in 
transcription and translation of downstream effectors. These effectors may function to 
prevent further damage, recover from the insult, or alternatively activate programmed cell 
death
3,39,64
. Interestingly, we show a novel way to increase cellular ATF4 levels that is 
independent of eIF2α phosphorylation. Here we show that the expression of either full-
length RGS2 or the eIF2Bε-binding domain of RGS2 (RGS2eb) is sufficient to 
significantly increase ATF4 expression without any detectable change in the level of p-
eIF2α (Fig. 3.3). Translational control by RGS2 may therefore provide an alternative 
mechanism in the induction of stress response factors, parallel to pathways mediated by 
p-eIF2α. This may also consequently lead to changes in cellular adaptability to stress. 
Consistent with this idea, increased ATF4 levels with RGS2 and RGS2
eb
 expression 
correlated with comparable increases in its downstream target CHOP (Fig. 3.3A, D), 
suggesting that RGS2 modulates the ATF4-CHOP stress-mediated pathways and their 
effects. The implications from this are significant as to our knowledge, this is the first 
report of an alternative mechanism to upregulate ATF4 from the known eIF2α-ATF4 
pathway and extends the known repertoire of mechanisms within the cellular stress 
response. This has important implications with respect to the molecular mechanisms 
involved in regulating the activity of cells during times of stress and understanding the 
cross-talk between stress response and apoptotic pathways. Additionally, this also 
suggests potential pharmacological targets important in modulating stress-related 
pathologies associated in the regulation of ATF4 expression. 
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Figure 3.3. RGS2 and RGS2
eb
 upregulates ATF4 protein levels independent of 
eIF2α phosphorylation. 3T3 fibroblasts were infected with adenoviruses encoding GFP 
(viral infection control), full-length RGS2, or the RGS2 eIF2Bε-binding domain 
(RGS2
eb
) at a multiplicity of infection of 50 for 48 hours. Non-infected (NI) cells were 
then treated with 2 μM thapsigargin (TH) for 2 hours as a positive control for the 
induction of ATF4 and eIF2α phosphorylation, or treated with 0.1% DMSO (vehicle 
control). ATF4-specific protein band is indicated by an arrowhead, NS = non-specific 
band. Two gels were run in parallel as described for Figure 3.2, and the same subsequent 
procedures were performed to obtain the immunoblots shown. (A) RGS2 and RGS2
eb
 
expression resulted in significant increase in cellular ATF4 levels (one-way ANOVA, p < 
0.0001), while no comparable increase in levels of phosphorylated eIF2α was observed. 
CHOP protein levels increased in a similar pattern. Immunoblots shown are 
representative of three independent experiments, the densitometric data of which are 
summarized in bar graphs as mean ± SEM for ATF4 (B), phosphorylated eIF2α (C), and 
CHOP (D) protein levels. After immunoblot for levels of phosphorylated eIF2α, 
membranes were stripped and reprobed for total eIF2α protein levels. The relative level 
of eIF2α phosphorylation was determined by taking the ratio of p-eIF2α to signal 
obtained with pan-eIF2α antibody. Control for equal protein loading was assessed via 
immunoblotting for β-tubulin. Statistical analysis was performed using one-way ANOVA 
followed by Dunnett’s post-hoc test on each condition versus non-infected vehicle 
control condition. **, Significant difference (p < 0.01). ***, Significant difference (p < 
0.0001). 
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3.1.3 RGS2 and RGS2eb upregulates ATF4 and CHOP 
translationally but not transcriptionally 
Our observations that RGS2 and RGS2
eb
 increase cellular protein levels of ATF4 and 
CHOP led us to examine whether such effects by RGS2 were strictly translational or due 
to increased gene expression, resulting in greater transcript levels available for 
translation. As shown in Figure 3.4, expression with RGS2 or RGS2
eb
 did not affect the 
relative mRNA levels of ATF4 compared to the levels observed in the positive control 
conditions via treatment with chemical stressors such as thapsigargin or tunicamycin. A 
similar ATF4 gene expression pattern was obtained using a different ATF4 primer set 
(Appendix D, Fig. D1). This suggests that the upregulation of ATF4 mediated by the 
expression of RGS2 and RGS2
eb
 observed in our immunoblot data (Fig. 3.3) was not due 
to increased transcript levels of ATF4. Rather, ATF4 is regulated via the ability of RGS2 
to affect the translational machinery and inhibit initiation, as well as the intrinsic 
properties of ATF4 mRNA, governing its translation. 
Surprisingly, CHOP mRNA levels did not increase as expected with the observed 
increases in ATF4 protein levels, which is a known transcriptional activator for CHOP 
gene expression. Similar to our assessment on ATF4 transcript levels, expression of 
RGS2 and RGS2
eb
 do not have an effect on CHOP transcription as no increase in CHOP 
transcript levels was observed (Fig. 3.5). Although CHOP gene expression can be 
induced by ATF4 and other stress-induced transcription factors, the CHOP gene also 
encodes multiple initiation sites, and as with ATF4, the translation of functional CHOP 
protein resulting from its proper open reading frame is enhanced by eIF2α 
phosphorylation
64,117,200,219
. The present results imply that RGS2 similarly is able to drive 
the expression of both ATF4 and CHOP via translational as opposed to transcriptional 
mechanisms. 
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Figure 3.4. Effect of RGS2 and RGS2
eb
 on levels of ATF4 transcription. 3T3 
fibroblasts were infected with adenoviruses encoding GFP (viral infection control), full-
length RGS2, or the RGS2 eIF2Bε binding domain (RGS2eb) at a multiplicity of infection 
of 50 for 48 hours. To confirm ATF4 upregulation, non-infected (NI) cells were treated 
with either 2 μM thapsigargin (TH) for 2 hours, 3 or 10 μg/ml tunicamycin (TM) for 6 
hours, or 0.1% DMSO (vehicle control). All stressors increased ATF4 mRNA levels, 
where treatment with thapsigargin and tunicamycin resulted in a significant induction of 
ATF4 transcription. *, Significant difference (p < 0.05). **, Significant difference (p < 
0.01). RGS2 and RGS2
eb
 expression did not result in an increase in ATF4 transcript 
levels. All mRNA levels are expressed as means normalized to the geometric mean of 
two stable reference genes (GAPDH and β2 microglobulin) ± SEM run in parallel 
through qPCR. Gene expression data presented are from three independent experiments, 
run in triplicate. Statistical analysis was performed using one-way ANOVA followed by 
Dunnett’s post-hoc test on each condition versus non-infected vehicle control condition. 
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Figure 3.5. Effect of RGS2 and RGS2
eb
 on levels of CHOP transcription. 3T3 
fibroblasts were infected with adenoviruses encoding GFP (viral infection control), full-
length RGS2, or the RGS2 eIF2Bε binding domain (RGS2eb) at a multiplicity of infection 
of 50 for 48 hours. To confirm CHOP upregulation, non-infected (NI) cells were treated 
with either 2 μM thapsigargin (TH) for 2 hours, 3 or 10 μg/ml tunicamycin (TM) for 6 
hours, or 0.1% DMSO (vehicle control). Stressors increased CHOP mRNA levels, where 
treatment with tunicamycin resulted in a significant induction of CHOP transcription. 
***, Significant difference (p < 0.0001). RGS2 and RGS2
eb
 expression did not result in 
an increase in CHOP transcript levels. All mRNA levels are expressed as means 
normalized to the geometric mean of two stable reference genes (GAPDH and β2 
microglobulin) ± SEM run in parallel through qPCR. Gene expression data presented are 
from three independent experiments, run in triplicate. Statistical analysis was performed 
using one-way ANOVA followed by Dunnett’s post-hoc test on each condition versus 
non-infected vehicle control condition. 
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3.1.4 RGS2eb induces caspase 3 activation 
Since we found ATF4 and CHOP protein levels increased with RGS2 and RGS2
eb
 
expression, we next assessed whether or not this may have downstream biological effects 
as the ATF4-CHOP pathway is known to promote apoptosis under irreparable stress. 
Apoptosis is a regulated and energy-dependent form of cell death that involves complex 
signalling pathways, one of the most well-known being the sequential activation of 
initiator caspases followed by effector caspases
87
. Caspase 3 is one of the main 
“executioner” caspases, the cleavage of which produces its active 17 kDa form that leads 
to cell destruction. Functions of activated caspase 3 include the cleavage of structural 
proteins, signalling molecules, other cytoplasmic and nuclear proteins, followed by the 
formation of apoptotic bodies which are then removed by macrophages
6,208,225–228
. 
Interestingly, our data show that only cells infected with RGS2
eb
 resulted in significant 
cleaved caspase 3 levels while cells infected with full-length RGS2 did not (Fig. 3.6, one-
way ANOVA, p = 0.0005; Dunnett’s post-hoc test, p < 0.0001). These results suggest 
possible functional domains found within full-length RGS2 that may be protective. While 
full-length RGS2 can reduce translation and drive increased levels of cellular ATF4 and 
CHOP, other protective effects might be in place to inhibit the activation of caspase 3. 
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Figure 3.6. Expression of RGS2
eb
 results in greater levels of cleaved caspase 3. 3T3 
fibroblasts were infected with adenoviruses encoding GFP (viral infection control), full-
length RGS2, or the RGS2 eIF2Bε binding domain (RGS2eb) at a multiplicity of infection 
of 50 for 48 hours. Non-infected (NI) cells were then treated with 2 μM thapsigargin 
(TH) for 2 hours as a positive control for the induction of caspase 3 activation, or treated 
with 0.1% DMSO (vehicle control). RGS2
eb
 expression showed significant caspase 3 
cleavage while no comparable level of cleaved caspase 3 was observed with full-length 
RGS2. Immunoblots shown are representative of three independent experiments, the 
densitometric data of which are summarized in the bar graph below as mean ± SEM by 
taking the ratio of cleaved caspase 3 to uncleaved caspase 3 levels. Control for equal 
protein loading was assessed via immunoblotting for β-tubulin. Statistical analysis was 
performed using one-way ANOVA followed by Dunnett’s post-hoc test on each 
condition versus non-infected vehicle control condition. ***, Significant difference (p < 
0.0001). 
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3.2 Modulation of the stress response by RGS2 
While we showed that RGS2 expression resulted in decreased total cellular protein levels 
and increased protein levels of ATF4 and CHOP without the phosphorylation of eIF2, we 
next assessed whether such effects by RGS2 may influence the responses and 
physiological outcomes of cells under states of stress. Increased expression and/or 
activity of regulatory components involved in protein quality control, such as ER 
molecular chaperones (e.g., BiP/GRP78, GRP94, calnexin), and processing enzymes 
(e.g., protein disulfide isomerase), would be adaptive to maintain cellular integrity, 
functionality, and survival, until homeostasis is re-established or the stressful stimulus is 
removed
229
. When stresses exceed tolerable limits and cells become dysfunctional 
however, activation of factors leading to apoptosis, such as ATF4 and CHOP, may be 
favourable.  
To investigate this, we infected 3T3 fibroblasts with adenoviruses at a multiplicity of 
viral infection of 10 that may more closely reflect moderate levels of RGS2 that may 
occur during stress (see Appendix A, Fig. A1 and A3) and still lead to a reduction in 
protein synthesis (refer to Fig. 3.1). Following infection, we used well-known chemical 
agents to induce cellular stress, such as tunicamycin, a natural inhibitor of N-linked 
protein glycosylation from Streptomyces sp. which leads to the disruption of post-
translational modification of proteins in the ER
229
, or thapsigargin, a compound that 
prevents calcium reuptake by inhibiting endoplasmic or sarcoplasmic reticulum calcium-
ATPases, thereby inducing ER stress, and is also shown to induce autophagy in 
mammalian cells
107,108
. In our studies, we also used staurosporine, a general protein 
kinase C inhibitor, as a way to induce cellular stress, as this agent is known to be a strong 
inducer of apoptosis
211,230
. 
We have been able to verify that our selection of pharmacological treatments does induce 
stress within fibroblasts. Factors involved in the cellular stress response and the UPR 
such as ATF4, CHOP, BiP/GRP78, XBP1s, and the activation of caspase 3, indicative of 
apoptosis, were indeed upregulated with these treatments (see Appendix B, Fig. B4) and 
thus served as appropriate positive controls in our experiments. Furthermore, we 
hypothesized that the translation inhibition abilities of RGS2 may augment the cellular 
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stress response pathways and the UPR. To test this idea, we assessed the role of RGS2 on 
the expression of key components involved in such pathways under experimentally 
induced stress conditions. 
3.2.1 RGS2 is transcriptionally upregulated by tunicamycin 
treatment 
RGS2 is known to be upregulated by various forms of stress including heat shock
159,183
, 
ischemia
177
, oxidative stress
186
, as well as agonist-induced Gαs- and Gαq/11-mediated 
signals associated in cellular hypertrophy
166,167,182
. Here, we observed that RGS2 gene 
expression is upregulated by tunicamycin in 3T3 fibroblasts (Fig. 3.7, two-way ANOVA, 
p = 0.0124). Additionally, this result is not from the infection using adenoviruses that 
encode for RGS2 as it was not detected by our primers (see Table 2.1) due to species 
differences of the cell type used (mouse) and the viral RGS2 construct (human). RGS2 
mRNA levels increased in a concentration-dependent manner with tunicamycin stress and 
treatment at 10 μg/ml resulted in an approximately two-fold increase compared to vehicle 
control conditions. 
 
 
 
 
 
 
 
 
 
 
55 
 
 
 
0
1
2
3
NI
Ad-RGS2
Ad-GFP
VEH 1 2 5 10
Tunicamycin [µg/mL]
R
e
la
ti
v
e
 R
G
S
2
 m
R
N
A
 l
e
v
e
ls
 
Figure 3.7. Dose-dependent increase in RGS2 gene expression with tunicamycin 
treatment. 3T3 fibroblasts were infected for 48 hours with adenoviruses encoding RGS2 
or GFP at an MOI of 10, or were left uninfected (NI). RNA was then isolated 6 hours 
after treatment with 0.1% DMSO (vehicle control) or tunicamycin at the indicated 
concentrations. Treatment with increasing concentrations of tunicamycin significantly 
increased cellular mRNA levels of RGS2 (p = 0.0124) and no effect on RGS2 
transcription was seen as a result of the infection with adenoviruses (p = 0.2763). 
Relative mRNA levels of RGS2 are expressed as means normalized to the geometric 
mean of two stable reference genes (GAPDH and β2 microglobulin) ± SEM run in 
parallel through qPCR. Data presented are from three independent experiments, run in 
triplicate. Statistical analysis was performed using two-way ANOVA, followed by 
Bonferroni post-hoc test. 
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3.2.2 Effect of RGS2 expression on stress-induced 
phosphorylation of eIF2α 
Phosphorylation of eIF2α is a hallmark of stress-induced inhibition of translation in order 
to decrease cellular protein load to conserve energy and resources. In mammals, four key 
kinases activated by different types of stress are known to converge and phosphorylate 
eIF2α120,199. These include GCN2, activated upon deficiencies in essential amino 
acids
69,119
; PERK, activated upon ER stress primarily as a result of dysregulation of 
protein synthesis
35,118,203
; PKR, activated during the presence of viral double-stranded 
RNA
118,120
; and HRI, activated during heme deficiency, oxidative stress, osmotic and heat 
shock
120,121
. Inhibition of de novo protein synthesis is considered a major defense 
mechanism against a wide variety of cellular stresses
3
. While global protein synthesis is 
reduced, particular key components involved in alleviating stressful conditions, such as 
the transcription factor, ATF4, are selectively translated through previously described 
alternative translational mechanisms. The eIF2α-ATF4 pathway is associated with 
several stress-response functions such as amino acid biosynthesis, ER-associated 
degradation, autophagy, and apoptosis
70
. Dysregulation of this pathway has been linked 
to numerous diseases such as cancer, metabolic disease, and neurodegenerative 
disorders
3,61,119,231
. 
To investigate whether the expression of RGS2 may modulate the activity of the eIF2α-
ATF4 pathway and provide a parallel mechanism to regulate stress response via its ability 
to inhibit translation at initiation, we first looked at the levels of eIF2α phosphorylation in 
RGS2 expressing cells under stress. We have assessed the induction of phosphorylated 
eIF2α using both tunicamycin and thapsigargin, however, treatment with tunicamycin 
gave very limited phosphorylation of eIF2α (data not shown) while thapsigargin was a 
more robust inducer of ER stress
76
 and induced the phosphorylation of eIF2α (Fig. 3.8). 
Interestingly, infection of cells with RGS2 adenovirus consistently resulted in 
significantly lower levels of phosphorylated eIF2α compared to GFP-infection controls 
(Fig. 3.8, two-way ANOVA, p = 0.0323). Induction of p-eIF2α peaked around 15 
minutes of thapsigargin treatment in RGS2 expressing cells whereas levels of p-eIF2α 
were still detected up to 2 hours of thapsigargin treatment in corresponding GFP 
57 
 
expressing cells. This suggests that RGS2 may have been helping to alleviate ER stress. 
Furthermore, this data supports our current findings on the translational control of ATF4 
and CHOP expression by RGS2 which appears to be independent of eIF2α 
phosphorylation. 
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Figure 3.8. RGS2 expression leads to lower levels of stress-induced eIF2α 
phosphorylation. 3T3 fibroblasts were infected with RGS2 or GFP-encoding 
adenoviruses (MOI = 10), or left uninfected (NI). Following 48 hours of infection, cells 
were treated with 2 μM of thapsigargin (TH) over the course of 2 hours and lysates were 
immunoblotted for levels of phosphorylated eIF2α. 0.1% DMSO was used as vehicle 
control. Under RGS2 infection conditions, significantly lower phosphorylated eIF2α 
levels were observed (two-way ANOVA, p = 0.0323), with peak amounts at 15 min of 
treatment with thapsigargin. GFP-infection controls showed sustained levels of 
phosphorylated eIF2α over the course of treatment. Membranes were stripped and 
reprobed for total eIF2α protein levels. Immunoblots shown are representative of four 
independent experiments, the densitometric data of which is summarized in the bar graph 
below as mean ± SEM, showing the relative level of eIF2α phosphorylation, determined 
by taking the ratio of p-eIF2α to signal obtained with pan-eIF2α antibody. Control for 
equal protein loading was assessed via immunoblotting for β-tubulin. 
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3.2.3 Effects of RGS2 on the transcriptional regulation of stress-
related targets of the UPR 
To assess the role of RGS2 in the CSR, we looked at changes in the expression of 
endpoints of the UPR, such as BiP/GRP78 and XBP1s, in response to RGS2 expression 
under induced stress. Treatment with tunicamycin or thapsigargin generally led to 
increased protein levels of both of these targets compared to non-stressed states 
(Appendix B, Fig. B4). However, the low sensitivity of the available antibodies to 
consistently detect stress-induced changes of these endpoints led us to assess our 
questions using more sensitive, robust, and quantitative methods, such as changes in gene 
expression through real-time PCR. While our data on ATF4 and CHOP protein levels 
provided insights on translational effects with the expression of RGS2, we also examined 
whether RGS2 may regulate the activity of other pathways of the UPR at the 
transcriptional level. 
3.2.3.1 Effect of RGS2 on BiP/GRP78 gene expression 
BiP/GRP78 is an ER chaperone belonging to the heat shock protein 70 kDa (Hsp70) 
family of proteins and has quality control functions in the synthesis of secretory proteins 
by mediating proper protein folding. BiP is also known as a stress signal-regulating 
protein, keeping the activity of the three major transmembrane sensors that mediate ER 
stress response pathways (PERK/ATF4, IRE1/XBP1, and ATF6) in check
215,216,232–
234
.Treatment with tunicamycin significantly increased mRNA levels of BiP/GRP78 in a 
dose dependent manner (Fig. 3.9, two-way ANOVA, p < 0.0001). However, no 
significant effect was seen with RGS2 expression on the gene expression of BiP (two-
way ANOVA, p = 0.5191). Assessment with Bonferroni post-hoc test showed that at the 
highest dose of tunicamycin, there was a significant difference (*p < 0.05) in BiP 
transcript levels in RGS2 expressing cells compared to GFP viral infection controls. 
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Figure 3.9. Dose-dependent increase of BiP gene expression with tunicamycin. 3T3 
fibroblasts were infected for 48 hours with adenoviruses encoding for RGS2 or GFP at an 
MOI of 10, or were left uninfected (NI). RNA was then isolated 6 hours after treatment 
with 0.1% DMSO (vehicle control) or tunicamycin at the indicated concentrations. 
Treatment with increasing concentrations of tunicamycin significantly increased cellular 
mRNA levels of BiP. Relative BiP mRNA levels are expressed as means normalized to 
the geometric mean of two stable reference genes (GAPDH and β2 microglobulin) ± 
SEM run in parallel through qPCR. Gene expression data presented are from three 
independent experiments, run in triplicate. Statistical analysis was performed using two-
way ANOVA followed by Bonferroni post-hoc test, where a significant difference in BiP 
transcript levels were observed in RGS2 expressing cells at the highest concentration of 
tunicamycin (*p < 0.05). 
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3.2.3.1.1 Effect of RGS2 on BiP ER stress response element 
promoter activity 
In response to the BiP/GRP78 real-time data obtained, we looked at the effects of RGS2 
expression on the activity of promoters containing ER stress response elements (ERSE), 
such as that present in the BiP gene
215
, as another method to evaluate whether RGS2 may 
affect gene expression of stress-adaptive proteins. Previous studies characterizing the 
promoter of BiP/GRP78 showed it to be highly active under stress
215,235
. This promoter 
region contains several heat shock elements (HSEs) and an ERSE that is regulated by 
ATF6
65
. This suggests a positive feedback mechanism between BiP and ATF6 within the 
UPR to increase protein folding capacity. Disruption of protein glycosylation processes 
within the ER results in increased expression of BiP/GRP78, however, little is known 
about the regulatory elements involved in the transcriptional activation of BiP/GRP78
215
. 
RGS2 is upregulated during thermal stress
159,186
 and recent studies show that this is 
mediated by the binding of heat shock transcription factor 1 (HSF1) to an HSE recently 
characterized in the RGS2 promoter
183
. HSF1 functions principally as an activator of heat 
shock proteins, such as HSP70 proteins (of which BiP is a member), to protect against 
proteotoxic stress resulting from heat shock
236,237
. Whether there is competition for HSF1 
binding during thermal stress is not known, but the fact that both RGS2 and BiP are 
upregulated by HSF1 in response to heat shock may lead to synergistic effects towards 
cell recovery. RGS2 functions to inhibit translation and whether this modulates the 
activity of parallel stress-response processes, such as in the expression of chaperones to 
increase protein folding capacity, is not well understood. Additionally, RGS2 has been 
shown to attenuate the transcription of  target genes associated with aberrant protein 
synthesis that can lead to pathological hypertrophy
166,167
. Therefore, it is unclear whether 
RGS2 may affect expression through its ability to inhibit translation or perhaps by 
directly modulating the activity of ERSEs found in the promoters of stress proteins like 
BiP, of which we assessed the latter. 
We co-transfected plasmids that encoded for FLAG-tagged RGS2 together with plasmids 
that encoded the BiP ERSE promoter region into 3T3 fibroblast cells. Relative changes in 
the activity of the promoter were quantified via fluorescence microscopy of the tdTomato 
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fluorescent reporter, tagged to BiP ERSE (see Appendix C, Fig. C1, for representative 
fluorescent images). Treatment with 5 μg/ml tunicamycin resulted in significantly greater 
tdTomato fluorescence compared to 0.1% DMSO vehicle-treated controls (Fig. 3.10A 
and B, two-way repeated measures ANOVA, p < 0.001). No temporal effects of 
tunicamycin treatment on BiP ERSE activity were apparent. Moreover, no significant 
effects were seen with RGS2 expression on BiP ERSE promoter activity (Fig. 3.10C and 
D, two-way repeated measures ANOVA, p > 0.05), which this corresponds to our real-
time data where we showed no effect by RGS2 on BiP transcription under tunicamcyin-
induced stress. 
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Figure 3.10. Dose- and time-dependent effects of tunicamycin and RGS2 expression 
on BiP ERSE promoter activity. Experiments were performed as described in materials 
and methods, where 3T3 fibroblasts were co-transfected with plasmids encoding for BiP 
ERSE-tdTomato together with full-length RGS2 (indicated with red lines) or pcDNA3.1 
empty vector (indicated with black lines) for 24 hours. Cells were then treated with 0.1% 
DMSO (vehicle control, indicated with solid lines) or 5 μg/ml tunicamycin (indicated 
with dotted lines). Fluorescent images were taken at the indicated time points of 
treatment. Data presented is the relative fluorescence intensity averaged from three 
independent experiments. Treatment with 5 μg/ml tunicamycin significantly increased 
BiP ERSE promoter activity (A and B, two-way repeated measures ANOVA, p < 0.001). 
Such levels were observed at 6 hours and 24 hours of treatment in RGS2-transfected 
conditions (A, Bonferroni post-hoc test, *p < 0.05 and **p < 0.01) and at 1.5, 3, 12, and 
24 hours after treatment in empty vector controls (B, Bonferroni post-hoc test, *p < 0.05, 
**p < 0.01 and ***p < 0.001). In panels C and D the same data were replotted and 
reanalyzed to evaluate whether RGS2 influences BiP promoter activity, however, no 
difference was observed between RGS2 and empty vector expressing cells in either the 
absence (C) or presence (D) of tunicamycin (two-way repeated measures ANOVA, p > 
0.05). 
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3.2.3.2 Effect of RGS2 on XBP1s transcript levels 
The activity of IRE1 makes up one of the three major branches of the UPR that is 
activated upon the accumulation of misfolded proteins during ER stress. One of the most 
well studied functions of activated IRE1 is its endoribonuclease activity to result in the 
splicing of a 26-nucleotide intron within the XBP1 mRNA transcript. This causes a 
frame-shift during the translation of this spliced variant to produce a functional 
transcription factor (XBP1s)
11,40
. In mammals, XBP1s activates the expression of targets 
associated in cell differentiation, lipid synthesis, ER biogenesis, protein folding and 
degradation
11,43
, and is therefore an important factor in the regulation of cellular 
responses during stress. Similar to our assessment on the role of RGS2 on BiP gene 
expression under stressed conditions, treatment with tunicamycin significantly increased 
XBP1s transcript levels in a dose dependent manner (Fig. 3.11, two-way ANOVA, p < 
0.0001). However, no significant effect was seen with RGS2 expression on the level of 
XBP1s transcription (two-way ANOVA, p = 0.2674). 
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Figure 3.11. Dose-dependent increase of XBP1s transcript levels with tunicamycin. 
3T3 fibroblasts were infected for 48 hours with adenoviruses encoding for RGS2 or GFP 
at an MOI of 10, or were left uninfected (NI). RNA was then isolated 6 hours after 
treatment with 0.1% DMSO (vehicle control) or tunicamycin at the indicated 
concentrations. Treatment with increasing concentrations of tunicamycin significantly 
increased cellular mRNA levels of XBP1s. Relative XBP1s mRNA levels are expressed 
as means normalized to the geometric mean of two stable reference genes (GAPDH and 
β2 microglobulin) ± SEM run in parallel through qPCR. Gene expression data presented 
are from three independent experiments, run in triplicate. Statistical analysis was 
performed using two-way ANOVA followed by Bonferroni post-hoc test, where no 
significant difference was seen with the expression of RGS2. 
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3.2.3.3 Effect of RGS2 on CHOP gene expression 
CHOP is a major transcription factor that functions predominately to promote cell death 
by initiating and enhancing the activity of apoptotic pathways
58,72,238
. Downstream of the 
ATF4-CHOP mediated apoptotic pathway during the UPR, CHOP upregulates a number 
of effector proteins such as Bax and Bak that functionally carry out the destruction of 
cells, meanwhile decreasing the expression of anti-apoptotic factors, such as those 
belonging to the Bcl-2 family of proteins
55,72,80,239
. CHOP gene expression significantly 
increased in a concentration-dependent manner with tunicamycin induced stress (Fig. 
3.12, two-way ANOVA, p <0.0001). Similar to BiP and XBP1s however, no significant 
differences in CHOP mRNA levels were seen with RGS2 expression (two-way ANOVA, 
p = 0.9571), suggesting no additive effect by RGS2 on stress-induced upregulation of 
CHOP. This further supports our findings presented in section 3.1.3 where although we 
showed that RGS2 and RGS2
eb
 expression on its own led to increased protein levels of 
CHOP in cells, the effect by RGS2 appeared to be translational in nature as no effect was 
seen on the transcription of CHOP. 
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Figure 3.12. Dose-dependent increase of CHOP transcript levels with tunicamycin. 
3T3 fibroblasts were infected for 48 hours with adenoviruses encoding for RGS2 or GFP 
at an MOI of 10, or were left uninfected (NI). RNA was then isolated 6 hours after 
treatment with 0.1% DMSO (vehicle control) or tunicamycin at the indicated 
concentrations. Treatment with increasing concentrations of tunicamycin significantly 
increased cellular mRNA levels of CHOP. Relative CHOP mRNA levels are expressed as 
means normalized to the geometric mean of two stable reference genes (GAPDH and β2 
microglobulin) ± SEM run in parallel through qPCR. Gene expression data presented are 
from three independent experiments, carried out in triplicate. Statistical analysis was 
performed using two-way ANOVA followed by Bonferroni post-hoc test, where no 
significant difference was seen with the expression of RGS2. 
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3.2.4 Expression of ATF4 and CHOP in response to cell stress 
ATF4 is a transcriptional activator of stress response targets involved in metabolism, 
nutrient uptake and amino acid biosynthesis, control of redox status, apoptosis and 
autophagy
222,240,241
. It does so by binding to CCAAT/enhancer binding protein-activating 
transcription factor (C/EBP-ATF) response element sequences in such target genes to 
increase their expression
3,63
. Since RGS2 can prevent translation at initiation, similar to 
the effect of p-eIF2α by inhibiting the formation of complete ribosomal complexes, we 
hypothesized that RGS2 might affect the expression of ATF4 and thereby modulate its 
known anti-apoptotic and pro-apoptotic effects during cellular stress. In section 3.1.3, we 
demonstrated that both full-length RGS2 and its eIF2Bε-binding domain, RGS2eb, were 
sufficient to substantially increase ATF4 protein levels in cells. Here, we assessed 
whether this effect would be enhanced during stressed states at moderate levels of RGS2 
expression. ATF4 protein levels increased in a concentration-dependent manner with 
tunicamycin, as shown in Figure 3.13 (A and B). Similarly, protein levels of CHOP 
increased in a concentration-dependent manner with tunicamycin treatment as well (Fig. 
3.13 A and C). Interestingly, no significant differences were seen with RGS2 expression 
however. This protein expression profile for CHOP parallels the corresponding gene 
expression data obtained in section 3.2.3.3, where CHOP mRNA levels increased in a 
dose dependent manner with tunicamcyin treatment but no difference in this effect was 
observed between RGS2- and GFP-expressing cells. 
3.2.5 Effect of RGS2 on stress-induced apoptosis 
During times of stress, it is expected that the primary responses of cells would be to 
increase cellular functions toward recovery and survival. However, if such responses are 
unsuccessful in mitigating the stressful conditions, the accumulation of dysfunctional 
cells and processes may be detrimental to the organism. Cells would therefore engage in 
a series of metabolic changes and activate caspase cascades, leading to apoptosis
57
. As 
described previously, caspase 3 is one of the effector caspases that contributes to the 
molecular and biochemical changes within cells leading to programmed cell death. 
Staurosporine is reported to be a strong inducer of apoptosis in various cell 
lines
208,209,213,242,243
 and was found to induce caspase 3 cleavage in our experiments (see 
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Appendix B, Fig. B4 F), and thus was used to investigate possible roles of RGS2 in 
stress-related apoptosis. Morphological changes characteristic of apoptosis were seen at 
all concentrations of staurosporine treatment, including cell shrinking, blebbing, 
formation of apoptotic bodies, and cytoplasmic fragmentation (see Appendix B, Fig. B2 
and B3), although these were not quantified. Viral infection on its own with either of the 
adenoviruses at an MOI of 10 did not appear to evoke cell death (Fig. 3.14). Caspase 3 
activation significantly increased in a dose-dependent manner with staurosporine 
treatment (Fig. 3.14, two-way ANOVA, p = 0.0001). Significant differences with RGS2 
expression were only observed at the highest dose of staurosporine, where greater 
caspase 3 activation was observed in RGS2 expressing cells than GFP expressing cells 
(Bonferroni post-hoc test, *p < 0.05). 
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Figure 3.13. Effects of RGS2 on stress-induced ATF4-CHOP pathways. 3T3 
fibroblasts were infected for 48 hours with adenovirus encoding for RGS2 or GFP 
(infection control) at an MOI of 10, or left uninfected (NI). Cells were then treated for 6 
hours with 0.1% DMSO (vehicle control), tunicamycin at the indicated concentrations, or 
not treated (NT). (A) Immunoblots show a dose-dependent increase in ATF4 and CHOP 
protein levels with tunicamycin treatment. ATF4-specific protein band is indicated by an 
arrowhead, NS = non-specific band. Immunoblot data shown are representative of three 
independent experiments where changes in ATF4 and CHOP protein levels were 
quantified via densitometry, as summarized in the corresponding bar graphs below, 
presented as mean ± SEM (B and C). Control for equal protein loading was assessed via 
immunoblotting for β-tubulin. 
 
 
 
 
 
 
 
 
 
 
 
73 
 
 
 
 
 
Veh 1 2 5 10
0
5000
10000
15000
20000
Ad-GFP
Ad-RGS2
Tunicamycin [µg/mL]
R
e
la
ti
v
e
 A
T
F
4
 d
e
n
s
it
o
m
e
tr
ic
 s
ig
n
a
l
(A
rb
it
ra
ry
 u
n
it
s
)
Veh 1 2 5 10
0
1000
2000
3000
4000
5000
Ad-RGS2
Ad-GFP
Tunicamycin [µg/mL]
R
e
la
ti
v
e
 C
H
O
P
 d
e
n
s
it
o
m
e
tr
ic
 s
ig
n
a
l
(A
rb
it
ra
ry
 u
n
it
s
)
 
 
 
 
A 
B C 
74 
 
 
 
Figure 3.14. Effects of RGS2 on stress-induced apoptosis. 3T3 fibroblasts were 
infected for 48 hours with adenovirus encoding for RGS2 or GFP (infection control) at an 
MOI of 10, or left uninfected (NI). To assess the role of RGS2 expression on apoptosis, 
cells were treated with staurosporine at the indicated concentrations for 4 hours. 
Treatment with staurosporine increased the levels of cleaved caspase 3 in a dose-
dependent manner. Membranes were then stripped and reprobed to assess total uncleaved 
caspase 3 protein levels. Relative caspase 3 activation was then taken as a ratio of cleaved 
caspase 3 signal to uncleaved caspase 3 signal. Immunoblot data shown are 
representative of three independent experiments and quantified via densitometry, as 
summarized in the corresponding bar graph below, presented as mean ± SEM. Control 
for equal protein loading was assessed via immunoblotting for β-tubulin. 
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Chapter 4  
4 Discussion 
We have previously shown that RGS2 is able to inhibit de novo protein synthesis as a 
result of its interaction with eIF2B and interference with eIF2-eIF2B GTP-exchange 
activity
160
. This limits the amount of activated eIF2-GTP that is a necessary component 
within the translational machinery for initiation to occur
160
. This effect is similar to those 
triggered by stresses that promote the phosphorylation of eIF2α, and in fact, many of the 
same stressors that trigger eIF2α phosphorylation also upregulate RGS2186,244. The 
inhibition of initiation leads to a reduction of global protein synthesis, allowing the 
conservation of energy and resources, but it also upregulates factors preferentially 
produced through alternative translation mechanisms, such as ATF4
61
. Whether or not the 
translational control abilities of RGS2 may contribute to alternative translation 
mechanisms and modulate stress response is not well understood. The goals of the studies 
presented in this thesis were to delineate other possible mechanisms in the regulation of 
stress response pathways, including apoptosis, and how they may be modulated by 
RGS2. We provide evidence demonstrating that RGS2 can modulate pathways of the 
UPR, in particular the eIF2α-ATF4 axis, and this adds to the current knowledge of the 
molecular mechanisms and components involved in the cellular stress response. 
4.1 Translational control by RGS2 increases the expression 
of stress response factors: A novel mechanism 
independent of eIF2α phosphorylation 
Mechanisms of the cellular stress response are highly conserved in all cells and, for the 
most part, the end result of exposure to stress depends on the damage sustained (e.g., if 
protein or DNA was damaged or if the stress was as a result of an imbalance in organic 
molecules and ions etc.) and less on the specific stimuli that first evoked the damage
2
. 
For example, thermal stress (i.e., heat shock), oxidative stress (i.e., reactive oxygen 
species), or known chemical compounds that can disrupt protein synthesis at the ER (e.g., 
tunicamcyin or thapsigargin), all can lead to the misfolding of proteins and result in 
cellular dysfunction. Consistent with this idea, several key kinases activated by such 
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stresses have been found to converge and phosphorylate eIF2 to inhibit initiation, 
suggesting that this is a pivotal target and molecular pathway taken to alleviate 
stress
29,239
. 
A variety of mechanisms exist that lead to the reduction of protein synthesis, most of 
which predominantly involve regulation at initiation. The rate of initiation is limited by 
the activities of eIF2 and eIF4F. eIF4F is a complex of eIF4 initiation factors composed 
of eIF4A, E, and G which are involved in the recruitment of an mRNA to a ribosome for 
translation to occur
245
. In particular, eIF4E is responsible for the recognition of the 5’cap 
structure of mRNAs facilitating their recruitment to a ribosome
245
. A family of eIF4E-
binding proteins blocks such functions of eIF4E, thereby regulating cap-dependent 
translation
246
. Moreover, the rate-limiting step in initiation is the GTP exchange cycle 
that occurs between eIF2 and eIF2B in order to generate activated eIF2 that is required to 
bring the initiator methionine to start the process of protein synthesis
114,247
. The most 
well-known mechanism to impede this involves the phosphorylation of eIF2α, which 
increases its binding affinity and sequesters the activity and availability of eIF2B
61,115,116
. 
While this reduces protein synthesis in general, some stress response proteins are 
selectively upregulated via alternative translation. Previously, our lab has shown that 
RGS2 can bind to eIF2B and inhibit protein synthesis in various cell types
160
. This 
provides a similar regulatory effect on protein translation. However, whether this effect 
by RGS2 modulates the expression of proteins produced through alternative translation 
mechanisms during stress was not known and was one of the aims addressed in this 
research. 
Thapsigargin induces ER stress by depleting ER calcium levels which further leads to the 
loss of activity of calcium-dependent ER chaperones, such as calnexin, resulting in the 
accumulation of unfolded proteins
16
. Interestingly, we showed that expression of RGS2 
under thapsigargin-induced stress led to lower levels of phosphorylated eIF2α. A possible 
explanation to this may be as a result of reduced protein synthesis by RGS2. The data 
presented in this thesis showed that the expression of RGS2 does indeed decrease total 
protein levels, implying an effect by RGS2 on translation, and complements previous 
studies from our lab which showed that RGS2 can interfere with the initiation machinery 
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and prevent de novo protein synthesis
160
. This would reduce protein load and the amount 
of unfolded proteins, thereby alleviating ER stress. Reversion of pathways of the UPR 
would be expected, such as the re-association of BiP to PERK, thereby silencing its 
kinase activity, which would explain the decreased levels of phosphorylated eIF2α. As 
well, total eIF2 appears to have been increased in RGS2-expressing cells (data not 
shown, p = 0.0271), which could also have affected the ratio of phosphorylated to total 
eIF2 in these cells. This increase in eIF2 may perhaps act as a compensatory mechanism 
as a result of reduced protein synthesis by RGS2 to balance basal translational needs of 
the cell to maintain functionality. 
The increased translation of ATF4 is generally attributed to the decrease in eIF2 
activation as a result of the phosphorylation of eIF2α. While previous studies from our 
lab identified RGS2 as another means to reduce levels of activated eIF2, it was not 
known whether this would increase ATF4. The current studies directly tested this and 
demonstrated that RGS2 does substantially induce ATF4 under non-stressed states. In 
fact, this effect could be achieved with just the 37 amino acids eIF2Bε-binding domain of 
RGS2 (RGS2
eb
). Furthermore, no measurable increase in level of phosphorylated eIF2α 
could be detected in either of these cases. This suggests that it is the inhibition of eIF2 
and not its phosphorylation that contributes to the molecular changes associated with 
reduced translation.  
To summarize, two major findings arise as a result of these studies. Firstly, RGS2 
expression can modulate the translation of genes normally only expressed under times of 
stress-induced inhibition of protein synthesis, and this is most likely attributed to the 
ability of RGS2 to inhibit translation and drive alternative translation mechanisms. 
Secondly, the upregulation of stress-induced effectors mediated by alternative translation 
mechanisms is a result of decreased eIF2 activity and not necessarily its phosphorylation. 
These findings outline a novel way to modulate pathways of stress response by RGS2, in 
addition to the known molecular repertoire mediated by phosphorylated eIF2a. 
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4.2 Effects of RGS2 on the enhanced expression of stress 
response factors occurs through translational means 
and not through transcription 
Our data presents an interesting finding in regards to how the expression of stress 
proteins is regulated. We showed that both RGS2 and RGS2
eb
 substantially increased 
cellular protein levels of ATF4 and CHOP without an increase in transcription of either 
of these two stress response factors.  
The mRNA molecules encoding stress-activated proteins are in some cases found to 
contain multiple start sites (triplet AUG sequences), leading to alternative open reading 
frames that give rise to different protein isoforms of a target gene, depending on where 
the ribosomal machinery initiates translation. These protein isoforms may have very 
different physical properties, such as in protein biochemistry and structure, which may 
influence its stability, activity, and/or functionality, and affect cellular physiology. As 
mentioned previously, the structural features of the mRNA transcripts themselves, the 
“scanning” mechanism of ribosomes to translate mRNA, and the availability of 
components required for the formation of competent initiation complexes (i.e., eIF2-
GTP-Met-tRNAi) can affect where ribosomes initiate translation and lead to the 
production of such protein isoforms
34,126
. During times of stress, the relative scarcity of 
activated eIF2-GTP leads to a delay in initiation, resulting in the tendency of scanning 
ribosomes to bypass upstream AUG sequences and promote initiation at downstream 
AUG sequences
34
. ATF4 is one such stress protein whose expression is regulated by such 
mechanisms, controlled by two open reading frames located upstream of the main 
opening reading frame that encodes for functional ATF4 in its transcript
63
. Here we 
provide direct evidence that this can also be achieved by RGS2 and more specifically 
through its inhibitory effects on translation by RGS2
eb
. RGS2
eb
 interacts with eIF2B 
which impedes the GTP-exchange activity between eIF2B and eIF2
160
 thereby reducing 
the amount of activated eIF2. ATF4 translation would therefore be expected to increase, 
which was observed in these present studies. Furthermore, as reported in literature, the 
presence of cellular ATF4 is predominantly regulated by its translation
62,63,70
 and post-
translational modifications affecting its stability
62
, and less on its transcription. ATF4 
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mRNA is ubiquitously found and in relatively abundant amounts
62,248
.  This possibly 
explains why no increase in ATF4 transcript levels was observed with RGS2 or RGS2
eb 
and also strongly points to its regulation more so by translational means. Less is known 
regarding the transcription of ATF4, although some studies report that transcriptional 
control of ATF4 can be stress-dependent
249,250
. The lack of a transcriptional effect by 
RGS2 is not due to its absence from the nucleus or inefficiencies in translocation to the 
nucleus. Although RGS2 does not have a nuclear import signal, nuclear accumulation of 
RGS2 does occur and it enters the nucleus by passive diffusion
251
. Many RGS proteins 
localize to the nucleus and in some cases have been shown to affect transcription
252,253
, 
although this has not been seen with RGS2.  
ATF4 is a transcriptional activator of CHOP, thus we expected that greater CHOP 
transcription would occur as a result of the increase in levels of ATF4 with RGS2 
expression. Interestingly, cells infected with RGS2 or RGS2
eb
 showed increased CHOP 
protein expression whereas CHOP transcription was essentially unaltered. CHOP mRNA 
consists of an upstream open reading frame that encodes a short 31 amino acids protein 
that strongly represses basal translation of functional CHOP by inhibiting translation 
reinitiation at the downstream CHOP open reading frame during quiescent 
conditions
64,218
. Therefore, similar to ATF4, CHOP protein expression is enhanced under 
times of reduced translation via alternative translation mechanisms which would explain 
our findings on the increased CHOP protein levels by RGS2. Additionally, the 
transcription of CHOP is known to be regulated by other stress-activated transcription 
factors, such as ATF6 and XBP1
72,223
. In fact, it has been reported that the presence of 
multiple transcription factors in the pathways of the UPR is required to maximally induce 
the transcription of CHOP
223,224
. A study by Okada et al. (2002) showed that the 
expression of ATF6 only induced a 2-fold increase in CHOP gene expression and 
overexpression of ATF4 alone was not sufficient for the induction of CHOP mRNA 
while the induction of both pathways resulted in more than a 20-fold induction of CHOP 
mRNA
224
. It is possible that CHOP gene expression may have been transiently 
upregulated by RGS2-promoted ATF4 translational upregulation but returned to baseline 
during the relatively long infection period, as opposed to the acute treatment times with 
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thapsigargin and tunicamycin. This provides a possible reason for the lack of an increase 
in CHOP transcription even though RGS2 significantly increased ATF4 protein levels.  
The disparate outcomes in protein and gene expression of both ATF4 and CHOP as a 
result of the expression of RGS2, plus the translational control abilities of RGS2, strongly 
suggests that RGS2 can promote alternative translation as a part of its role in the stress 
response. 
4.3 Effects of RGS2 on the expression of stress-activated 
endpoints of the UPR 
For the most part, moderate expression of RGS2 did not appear to either increase or 
decrease the expression of components of the UPR under experimentally induced stress. 
This is surprising considering the effects we observed on ATF4 and CHOP protein 
expression as a result of the expression of RGS2 or RGS2
eb
 on its own, as well as the 
lowered levels of phosphorylated eIF2α with RGS2 expression. These included endpoints 
associated with cell recovery, such as the XBP1 splice variant (XBP1s), which is a 
reportedly active and stable transcription factor involved in the transcriptional activation 
of genes encoding for chaperones and degradation enzymes
203
. While levels of the 
spliced transcript of XBP1 significantly increased with tunicamycin induced stress, there 
was no effect with RGS2, suggesting that RGS2 may not affect the IRE1-XBP1s branch 
of the UPR. However, although RGS2 did not appear to affect XBP1s expression, RGS2 
may influence stress-activated IRE1 pathways through other means. For example, we 
have not tested whether the expression of RGS2 may affect other stress-response 
processes mediated by IRE1 such as the activation of mRNA degradation (i.e., RIDD)
32,47
 
or apoptotic pathways
11,13
, or perhaps on the activation of IRE1 itself through assessing 
its phosphorylation. 
BiP is a chaperone that is essential for the proper folding of proteins in the ER. Inhibition 
of translation by RGS2 would decrease protein load to prevent further accumulation of 
unfolded or misfolded proteins, and thus alleviates or reduces the effects of stress. This 
would reduce the need for the expression of BiP and conserve energy and resources. 
Therefore, it was predicted that BiP expression levels would be lower in conditions with 
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RGS2; however this was not the case. Treatment with tunicamycin significantly increased 
BiP transcript levels and RGS2 expression did not appear to have an effect on this. In 
fact, at the highest concentration of tunicamycin, greater BiP transcript levels were seen 
with RGS2 expression. The reasons for this are unclear but points to the fact that BiP 
appears to be regulated transcriptionally under times of cell stress. Also, this provides 
further evidence that RGS2 does not appear to have functions in transcription, consistent 
with the ATF4 and CHOP gene expression data presented. This is further supported 
through our assessment on BiP ERSE promoter activity where we saw no effect by RGS2 
on tunicamycin-induced BiP promoter activity. This suggests that other factors may be 
recognizing and binding to the BiP ERSE, such as ATF6
50,65
, that is driving its activity 
during stress but not RGS2. 
4.4 Effects of RGS2 on stress-induced apoptosis 
A recent study by Endale et al. (2010) showed that the upregulation of RGS2 by ischemic 
stress resulted in greater astrocyte cell death
177
. Since RGS2 can prevent translation at 
initiation, similar to the effects by eIF2α phosphorylation, we hypothesized that RGS2 
might modulate the expression of factors of the CSR, such as ATF4, and thereby 
modulate its downstream anti-apoptotic or pro-apoptotic effects under states of stress. We 
found that ATF4 protein levels increased in a concentration-dependent manner with 
tunicamycin induced stress. Similarly, protein levels of CHOP increased in a 
concentration-dependent manner with tunicamycin treatment as well and these increases 
were comparable  to levels found in neurons treated with tunicamycin
223
. However, 
RGS2 expressing cells did not induce any greater levels of ATF4 or CHOP proteins as 
that seen with the GFP viral infection controls under stress. Also, cells infected with 
adenoviruses encoding for the expression of RGS2 and treated with staurosporine only 
showed greater caspase activity than GFP-infection controls at the highest concentration 
of the stress inducer. Therefore, whether RGS2 may be pro-apoptotic during stress 
remains elusive. 
RGS2 can perhaps affect different but overlapping pathways of the cell stress response 
other than the UPR. These include the mitogen-activated protein kinase (MAPK) 
pathways, heat shock response, or oxidative stress response
1,2
, and the multiplicity of its 
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effects may possibly explain the minimal effects by RGS2 on endpoints of the CSR under 
experimentally-induced stress seen here. Previous studies conducted in our lab showed 
intriguing results whereby RGS2 expression appeared to alter the activation of various 
MAP kinases. MAPKs make up one of the largest family of protein kinases involved in 
the transduction and amplification of cellular signals, including those initiated by GPCRs, 
and regulate major cellular processes such as cell proliferation, differentiation, and 
death
254–256
. Additionally, MAPK signalling pathways are shown to be activated in 
response to ER stress and form part of the UPR
255,257
. Our lab has previously shown that 
RGS2 can inhibit agonist-induced Gαq/11- and Gαs-mediated hypertrophy in 
cardiomyocytes and this may be attributed to the observed decreases in activation of the 
MAP kinase ERK1/2 or other stress-activated kinases such as Akt
166,167
. This makes 
sense as ERK 1/2 and Akt are both highly involved in cell growth and proliferation 
functions
254–257
, so a decrease in the activity of such MAPKs would be expected to 
prevent hypertrophy. Those studies also showed an increase in the levels of activated 
JNK and p38 with RGS2 overexpression
166,167
, and these MAP kinases are linked to pro-
apoptotic functions
254,255,257–259
, possibly explaining the pro-apoptotic effects of RGS2. 
Indeed, the activation of p38 appears to be an important component in RGS2-induced 
astrocyte cell death under ischemic stress
177
. Endale et al. (2010) showed that the 
inhibition of p38 activation by a selective inhibitor prevented RGS2 upregulation and 
resulted in greater astrocyte survival during ischemia
177
. These studies indicate a 
relationship between p38 MAPK activation and RGS2 to affect physiological outcomes, 
however, this may be cell-type specific as thapsigargin-treated RGS2-expressing 3T3 
fibroblasts did not affect p38 activation (data not shown, p > 0.05), and this may also be 
attributed to the timing of detection of its activation. Thus, the cross-talk between RGS2 
and the activity of the MAP kinase pathways may very well influence the molecular 
pathways in cellular stress response but this remains equivocal based on our results and 
may involve other factors. 
The protein data presented here suggests that RGS2 may be pro-apoptotic. Upstream of 
caspase 3, increases in ATF4 and CHOP were observed with RGS2 and RGS2
eb
 
expression. Additionally, other pathways of the cell stress response and the UPR, such as 
those regulated by IRE1, are known to mediate apoptosis as well
13
 and they may have 
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contributed to the effects we observed, although we did not specifically test them in this 
current body of work. Moreover, expression of RGS2
eb
 resulted in significant increases in 
caspase 3 cleavage. Under in vitro models of stress, greater levels of cleaved caspase 3 
were observed in RGS2 expressing cells compared to GFP viral infection controls, albeit 
at the highest concentration of the stress treatment with staurosporine, further suggesting 
a pro-apoptotic effect by RGS2. Depending on the context and physiological state of the 
cell, cell death may be preferable when the stress cannot be resolved to remove damaged 
and dysfunctional cells before detrimental effects occur. 
4.5 Role of RGS2 in the stress response 
The relative benefits of RGS2 expression during stress are unclear and based on the 
findings presented here, there may potentially be multiple roles for RGS2 in the stress 
response, some of which may be distinct from its translational control ability. Decreased 
protein synthesis is beneficial during times of stress to conserve energy and resources but 
this also leads to the preferential upregulation of proteins such as ATF4 and CHOP, 
which are known to promote apoptosis. Outside of the pro-apoptotic effects of ATF4 and 
CHOP, both also have important physiological and protective functions in cell stress 
responses. ATF4 upregulates the expression of NADH-cytochrome B5 reductases and 
asparagine synthetases to combat oxidative stress or increase amino acid transport during 
times of amino acid deficiency, respectively
62
. CHOP regulates the expression of a 
variety of genes involved in cell differentiation, proliferation and immune functions
72
. 
Therefore, the expression of these two factors forms an important component in stress 
response. We showed that the expression of RGS2 and RGS2
eb
 alone can substantially 
increase the levels of both of these factors and therefore may modulate physiological 
outcomes in cell stress responses. One may speculate that the structural and biochemical 
differences between the full-length RGS2 and the much shorter RGS2
eb
 may lead to 
differences in their cellular localization (i.e., RGS2
eb
 may be more strongly and rapidly 
recruited to ribosomal complexes to affect initiation factors, resulting in greater induction 
of ATF4 and CHOP) and/or potency. Indeed, Heximer et al. (2001) showed that 
truncation mutants of RGS2 exhibit different subcellular localization, so this is highly 
probable with RGS2
eb
 as well and it might lead to different physiological outcomes
251
. 
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Additionally, the expression of RGS2
eb
 increased the levels of cleaved caspase 3, 
implying pro-apoptotic effects. Whether this is linked to the increase in ATF4 and CHOP 
expression is uncertain as such increases in caspase 3 activation were not seen with the 
expression of full-length RGS2. This suggests that RGS2 has different functional 
domains and these are required to “fine-tune” its effects in stress response. On one hand, 
the translational control ability mediated by its RGS2
eb 
domain ensures the reduction in 
protein synthesis and drives the upregulation of stress response factors such as ATF4 and 
CHOP for their protective effects during stress. On the other hand, other domains within 
the full-length RGS2 may exist to ensure the repression of ATF4-CHOP mediated 
apoptotic effects. 
We and others have identified different domains of RGS2 that mediate other important 
cellular processes. Canonical functions of RGS2 include its activities to modulate GPCR 
and G protein-mediated signals, either through its GTPase-accelerating activity on Gα 
subunits mapped to the conserved 120 amino acids RGS domain
142
, or indirectly via 
affecting G protein-mediated effectors
149–151,164,260
. The physiological importance of this 
is shown where overexpressed RGS2 can block agonist-induced Gαq/11- and Gαs-
mediated cellular hypertrophy
166,167
, while a loss of endogenous RGS2 can exacerbate 
cellular hypertrophy
168
. Our lab has also shown that inhibition of heat shock-induced 
RGS2 upregulation via siRNA knockdown diminishes the repression of de novo protein 
synthesis, implicating that RGS2 expression as a cellular mechanism in regulating 
translation in response to stress
159
. Furthermore, several studies have shown the 
importance in the regulation of G protein-mediated signals and protein synthesis and the 
cross-talk between these two cellular processes in regulating cardiac physiology
127,261,262
. 
RGS2 has been shown to be important in these processes, where the eIF2B-interacting 
domain of RGS2 is shown to be protective against GPCR agonist-induced hypertrophy in 
cardiomyocytes
134
, and RGS2-null mice experience greater cardiac morbidity and 
mortality with induced pressure-overload on the heart
187
. Other functional domains 
identified in RGS2 include a stretch of amino acids from residues 1–82, situated outside 
of the RGS domain, that interacts with TRPV6 ionotropic receptors and disrupt ionic 
currents
158
, while another 20 amino acids domain, also located outside of the RGS 
domain, appears to have functions in enhancing microtubule polymerization affecting 
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cellular structure
157
. A study by Dusonchet et al. (2014) also showed RGS2 to be an 
interacting partner of leucine-rich repeat kinase 2 (LRRK2), likely via its GAP domain. A 
growing body of work show that mutations in the LRRK2 gene have emerged to be a 
genetic determinant in Parkinson’s disease, and the same group of researchers showed 
that RGS2 appears to be protective against mutant LRRK2-induced neurite shortening by 
regulating the GTPase and kinase activities of LRRK2
263
. Several important functional 
domains exists in full-length RGS2 that would not be present in RGS2
eb
 which may 
explain some of the molecular differences seen in these present studies between RGS2 
and RGS2
eb
. While it is uncertain whether these domains or ones yet to be identified in 
RGS2 may function to modulate pathways of the UPR and be a repressor of caspase 3, it 
is clear from these current results that the RGS2 eIF2Bε-binding domain appears to drive 
an opposite and pro-apoptotic effect. 
Recently, studies have characterized four initiator methionines in the mRNA of RGS2 at 
residues 1, 5, 16, and 33 that give rise to different protein isoforms of RGS2
264
. 
Structurally, all four protein products still contain the conserved RGS domain and 
RGS2
eb
. Functionally, all four RGS2 isoforms are still able to carry out its activities in 
attenuating Gαq/11-mediated signals, however isoforms arising from translation at 
residues 16 and 33 result in RGS2 products having impaired adenylyl cyclase activity
264
. 
The presence of alternative translation start sites suggests the possibility of RGS2 being 
differentially regulated during times of stress, similar to that of other stress proteins, 
further suggesting roles of RGS2 in stress response. Currently, it is not known whether 
particular initiation start sites are preferentially used during stress and, if so, whether the 
resulting products have altered activity in its other functional domains, i.e., RGS2
eb
, 
thereby affecting its translational control abilities. Ribosomal footprint profiling, a 
technique which can provide a global snapshot of only the mRNAs that are actively being 
translated, i.e., bound by ribosomes, at a particular moment
265
, may be valuable to 
determine which initiation start sites of RGS2 are being translated under different 
conditions, such as during stressed states. Collectively, the results presented here 
demonstrate the potential for multiple roles of RGS2 in the stress response (Fig. 4.1). 
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Figure 4.1. Summary of findings. Currently, our data shows the potential for multiple 
roles of RGS2 in the stress repsonse. (A) We have demonstrated that RGS2, apparently 
via its eIF2B-binding domain (RGS2
eb
), can promote alternative translation in a manner 
analogous to that mediated by the phosphorylation of eIF2α. Furthermore, the present 
results imply that RGS2 and RGS2
eb
 drive the expression of both ATF4 and CHOP via 
translational as opposed to transcriptional mechanisms, and that RGS2
eb
 is pro-apoptotic. 
(B) As expected, stress induced the phosphorylation of eIF2α, increased the expression of 
factors invovled in cell stress response such as ATF4, CHOP, BiP, XBP1s, and increased 
caspase 3 cleavage. Additionally, treatment with tunicamycin resulted in an increase in 
RGS2 mRNA levels. In contrast to our original speculation, moderate expression of 
RGS2 did not appear to either increase or decrease the expression of any of these factors 
under experimentally induced stress, although lower levels of phosphorylated eIF2α were 
observed in RGS2 expressing cells.  
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4.6 Conclusion and Future Perspectives 
In summary, our data strongly implies that RGS2 is an important component of the stress 
response. We show that RGS2 is a key component in driving alternative translation-
dependent mechanisms that activate the ATF4-CHOP pathway associated with the CSR. 
More specifically, RGS2
eb
 on its own was sufficient to significantly upregulate cellular 
ATF4 protein levels, without the presence of p-eIF2α. Previously, the activation of ATF4 
was predominantly known to be regulated by decreased eIF2 activation as a result of 
stress-induced phosphorylation of eIF2α. We are the first to show that the upregulation of 
ATF4 and its downstream effects can occur without the phosphorylation of eIF2α and we 
present a novel mechanism mediated in part by translational functions of RGS2. We 
provide evidence that alternative translation mechanisms triggered by eIF2α 
phosphorylation are due to decreased eIF2 activity and not phosphorylation per se, and 
thus extend the known repertoire of mechanisms involved in the CSR. RGS2
eb
-infected 
fibroblasts also increased levels of ATF4, CHOP, and cleaved caspase 3, suggesting that 
this may be the domain in RGS2 that promotes apoptosis under stressed conditions and 
may be an important target to mitigate apoptosis-mediated diseases and pathologies. 
Investigating the physiological implications of RGS2-mediated activation of the ATF4-
CHOP pathway would be of interest to assess whether or not the effects seen here with 
RGS2 and RGS2
eb
 expression do lead to greater cell death. Differences in cell viability 
between RGS2-positive and RGS2-negative cells under stress may be indicative of the 
relative protective or detrimental effects correlated with the expression of RGS2 as it 
currently appears that RGS2 may have multiple roles in the stress response that may be 
cell type- or stress-dependent. 
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Appendices 
Appendix A: Verification of adenoviral titres, multiplicity of infection, and viral 
infection efficiency 
 
Figure A1. Verification of adenoviral titres and protein expression via 
immunoblotting. 3T3 fibroblasts were infected for 48 hours at the indicated multiplicity 
of infection (MOI) with adenoviruses encoding full-length His6-tagged human RGS2 or 
GFP. Purified His6-tagged RGS2 protein samples were run in parallel in SDS-PAGE gels 
as positive control for RGS2 expression. 
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Figure A2. Expression of adenoviral encoded proteins. 3T3 fibroblasts were infected 
with increasing amounts of adenoviruses encoding for the expression of GFP, starting at 
an MOI of 0 (no virus) up to 100. Levels of expression of adenoviral encoded proteins 
were assessed via fluorescent microscopy for GFP expressing cells. Representative 
images on the level of GFP expression are shown with respective light microscopy 
images below to show equal cell density after 48 hours of infection with the adenoviruses 
(a-d). 
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Figure A3. Assessment of endogenous levels of RGS2 with forskolin treatment. 3T3 
fibroblasts were infected with adenoviruses encoding GFP (viral infection control) or 
full-length RGS2 at the indicated range of multiplicity of infection (MOI). A sample of 
uninfected fibroblasts (NI) was treated with 100uM water-soluble forskolin (FSK) or was 
treated with 0.1% DMSO (vehicle control) for 3h to assess physiological levels of 
endogenous RGS2 during upregulation. 6xHis-tagged RGS2 protein band from the viral 
infections is indicated by an asterisk (*), endogenous RGS2 protein band is indicated 
with a white arrowhead. An MOI of 10 was selected in our studies to study the effects of 
moderate levels of RGS2 expression on pathways of the CSR under experimentally 
induced stress. 
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Appendix B: Verification of drug treatments to induce cell stress and the expression 
of stress-activated targets 
 
 
 
Figure B1. Morphological changes in 3T3 fibroblasts after treatment with 
tunicamycin. (A) Untreated 3T3 cells grown to approximately 80-90% confluency after 
infection with adenoviruses. (B) 0.1% DMSO (vehicle control) treated cells grown to the 
same confluency post-infection. (C) Tunicamycin (5 μg/ml) treated cells grown to the 
same confluency post-infection. 
A 
B 
C 
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Figure B2. Morphological changes in 3T3 fibroblasts after treatment with 
staurosporine. (A) Untreated 3T3 cells grown to approximately 80-90% confluency after 
infection with adenoviruses. (B) Staurosporine (2 μM) treated cells grown to the same 
confluency post-infection. Cell blebbing and shrinkage was evident as early as 4 hours of 
treatment. 
A 
B 
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Figure B3. Dose-dependent effects of staurosporine (ST) on the morphology of 3T3 
fibroblasts. Cytotoxic effects such as cellular blebbing and shrinkage associated with cell 
death was evident with staurosporine treated cells compared to non-treated (NT) or 0.1% 
DMSO (Veh) treated controls. Images were obtained 4 hours post-treatment with 
staurosporine at the indicated concentrations. 
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Figure B4. Immunoblots showing the effects of tunicamycin (TM), thapsigargin 
(TH), or staurosporine (ST) treatment on the expression of stress-activated proteins 
in 3T3 fibroblasts. Cells were treated with the indicated drug (+) or 0.1% DMSO vehicle 
control (-).Treatment with TM (5 μg/ml) or TH (1 μM) lasted for 24 hours, treatment 
with ST (2 μM) lasted for 6 hours, cells were then lysed and total protein from lysates 
were collected and immunoblotted for the indicated targets (n = 2-3). BiP/GRP78 was 
upregulated by TM and TH treatment (A, B). TM also induced ATF4 expression as 
highlighted by the arrowhead, NS = non-specific protein band. Protein lysates extracted 
from a full-body ATF4 knockout mouse embryo (E16.5) was used as a negative control 
(C). Greater levels of the spliced XBP1 variant (XBP1s) were observed in cells treated 
with TM (D). Treatment with TH and ST was shown to activate caspase 3 (E, F). β-
tubulin or GAPDH was used as a protein loading control. 
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Appendix C: Effects of RGS2 on BiP ER stress response element promoter activity 
 
Figure C1. Representative fluorescent images showing the effects of tunicamycin 
and RGS2 expression on BiP ERSE-tdTomato promoter activity. 3T3 fibroblasts 
were co-transfected with plasmids encoding for the BiP ERSE promoter tagged with 
tdTomato together with full-length RGS2 or pcDNA3.1 empty vector (transfection 
control) for 24 hours. Cells were then treated with 0.1% DMSO (vehicle control) or 5 
μg/ml tunicamycin and fluorescent images were taken over a course of 24 hours to assess 
for differences in the level of BiP ERSE promoter activity. Image analysis to quantify 
total fluorescence was performed using ImageJ as described in Materials and Methods. 
Images are representative of three independent experiments. 
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Appendix D: Effects of RGS2 and RGS2
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 expression on ATF4 transcription 
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Forward Primer         Forward Primer 
5’-TCTTGGACTAGAGGGGCAAA-3’      5’-GATCTTTTTGCCCCTCTAGTC-3’ 
 
Reverse Primer         Reverse Primer 
5’-GGGACAGATTGGATGTTGGA-3’      5’-TCAACTTCACTGCCTAGCTCT-3’ 
 
Figure D1. Effect of RGS2 and RGS2
eb
 expression on ATF4 mRNA levels. 3T3 
fibroblasts were infected with adenoviruses encoding GFP (viral infection control), full-
length RGS2, or the RGS2 eIF2Bε binding domain (RGS2eb) at a multiplicity of infection 
of 50 for 48 hours. To confirm ATF4 upregulation, non-infected (NI) cells were treated 
with either 2 μM thapsigargin (TH) for 2 hours, 3 or 10 μg/ml tunicamycin (TM) for 6 
hours, or 0.1% DMSO (vehicle control). All stressors increased ATF4 mRNA levels 
while ATF4 transcript levels did not show a significant change with RGS2 and RGS2
eb
 
expression. Here we show that similar ATF4 gene expression profile was obtained using 
two different ATF4 primer sets (A and B), of which the primer sequences are listed 
below. All mRNA levels are expressed as means normalized to the geometric mean of 
two stable reference genes (GAPDH and β2 microglobulin) run in triplicate in parallel 
through qPCR (n = 1). 
 
 
A B 
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